<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72780</article-id><article-id pub-id-type="doi">10.7554/eLife.72780</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>METTL18-mediated histidine methylation of RPL3 modulates translation elongation for proteostasis maintenance</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-249087"><name><surname>Matsuura-Suzuki</surname><given-names>Eriko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1485-7959</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-41395"><name><surname>Shimazu</surname><given-names>Tadahiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2331-091X</contrib-id><email>tshimazu@riken.jp</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249088"><name><surname>Takahashi</surname><given-names>Mari</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9995-0019</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249089"><name><surname>Kotoshiba</surname><given-names>Kaoru</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90725"><name><surname>Suzuki</surname><given-names>Takehiro</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249090"><name><surname>Kashiwagi</surname><given-names>Kazuhiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6470-5817</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249091"><name><surname>Sohtome</surname><given-names>Yoshihiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9165-6720</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249092"><name><surname>Akakabe</surname><given-names>Mai</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249093"><name><surname>Sodeoka</surname><given-names>Mikiko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1344-364X</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41872"><name><surname>Dohmae</surname><given-names>Naoshi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5242-9410</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-218390"><name><surname>Ito</surname><given-names>Takuhiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3704-5205</contrib-id><email>takuhiro.ito@riken.jp</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund16"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-79831"><name><surname>Shinkai</surname><given-names>Yoichi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6051-2484</contrib-id><email>yshinkai@riken.jp</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-153504"><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7724-3754</contrib-id><email>shintaro.iwasaki@riken.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>RNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research</institution><addr-line><named-content content-type="city">Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution>Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research</institution><addr-line><named-content content-type="city">Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023rffy11</institution-id><institution>Laboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research</institution></institution-wrap><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010rf2m76</institution-id><institution>Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science</institution></institution-wrap><addr-line><named-content content-type="city">Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010rf2m76</institution-id><institution>RIKEN Center for Sustainable Resource Science</institution></institution-wrap><addr-line><named-content content-type="city">Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff6"><label>6</label><institution>Synthetic Organic Chemistry Lab, RIKEN Cluster for Pioneering Research</institution><addr-line><named-content content-type="city">Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Chiba</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Qing</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>08</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e72780</elocation-id><history><date date-type="received" iso-8601-date="2021-08-04"><day>04</day><month>08</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-05-26"><day>26</day><month>05</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-07-29"><day>29</day><month>07</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.07.29.454307"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72780-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-72780-figures-v1.pdf"/><abstract><p>Protein methylation occurs predominantly on lysine and arginine residues, but histidine also serves as a methylation substrate. However, a limited number of enzymes responsible for this modification have been reported. Moreover, the biological role of histidine methylation has remained poorly understood to date. Here, we report that human METTL18 is a histidine methyltransferase for the ribosomal protein RPL3 and that the modification specifically slows ribosome traversal on Tyr codons, allowing the proper folding of synthesized proteins. By performing an in vitro methylation assay with a methyl donor analog and quantitative mass spectrometry, we found that His245 of RPL3 is methylated at the τ-<italic>N</italic> position by METTL18. Structural comparison of the modified and unmodified ribosomes showed stoichiometric modification and suggested a role in translation reactions. Indeed, genome-wide ribosome profiling and an in vitro translation assay revealed that translation elongation at Tyr codons was suppressed by RPL3 methylation. Because the slower elongation provides enough time for nascent protein folding, RPL3 methylation protects cells from the cellular aggregation of Tyr-rich proteins. Our results reveal histidine methylation as an example of a ribosome modification that ensures proteome integrity in cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Translation</kwd><kwd>PTM</kwd><kwd>Methylation</kwd><kwd>Ribosome</kwd><kwd>Ribosome profiling</kwd><kwd>proteostasis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006264</institution-id><institution>RIKEN</institution></institution-wrap></funding-source><award-id>Pioneering project</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name><name><surname>Shinkai</surname><given-names>Yoichi</given-names></name><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006264</institution-id><institution>RIKEN</institution></institution-wrap></funding-source><award-id>Aging Project</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006264</institution-id><institution>RIKEN</institution></institution-wrap></funding-source><award-id>Collaboration seed fund</award-id><principal-award-recipient><name><surname>Matsuura-Suzuki</surname><given-names>Eriko</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006264</institution-id><institution>RIKEN</institution></institution-wrap></funding-source><award-id>Incentive Research Project</award-id><principal-award-recipient><name><surname>Matsuura-Suzuki</surname><given-names>Eriko</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006264</institution-id><institution>RIKEN</institution></institution-wrap></funding-source><award-id>BDR Structural Cell Biology Project</award-id><principal-award-recipient><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>JP20H05784</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP17H04998</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP19K22406</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP21gm1410001</award-id><principal-award-recipient><name><surname>Iwasaki</surname><given-names>Shintaro</given-names></name><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP18H03991</award-id><principal-award-recipient><name><surname>Shinkai</surname><given-names>Yoichi</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP18H05530</award-id><principal-award-recipient><name><surname>Shinkai</surname><given-names>Yoichi</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP21K06026</award-id><principal-award-recipient><name><surname>Matsuura-Suzuki</surname><given-names>Eriko</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP21am0101082</award-id><principal-award-recipient><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP20K06497</award-id><principal-award-recipient><name><surname>Shimazu</surname><given-names>Tadahiro</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP19H03172</award-id><principal-award-recipient><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>JP21H05281</award-id><principal-award-recipient><name><surname>Ito</surname><given-names>Takuhiro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>METTL18 methylates histidine 245 of ribosomal protein RPL3, retards ribosome traversal at tyrosine codons, and thus ensures nascent protein folding for proteostasis maintenance.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Protein methylation is an integral post-translational modification (PTM) that contributes to the critical role of epigenetics. This modification influences the function of proteins and provides a convertible platform for the modulation of cellular processes, including interactions with other molecules, protein structure, localization, and enzymatic activity (<xref ref-type="bibr" rid="bib6">Biggar and Li, 2015</xref>; <xref ref-type="bibr" rid="bib8">Clarke, 2018</xref>; <xref ref-type="bibr" rid="bib44">Murn and Shi, 2017</xref>; <xref ref-type="bibr" rid="bib52">Rodríguez-Paredes and Lyko, 2019</xref>). Whereas the majority of protein methylation has been observed on lysine and arginine amino acids (<xref ref-type="bibr" rid="bib6">Biggar and Li, 2015</xref>; <xref ref-type="bibr" rid="bib8">Clarke, 2018</xref>; <xref ref-type="bibr" rid="bib44">Murn and Shi, 2017</xref>; <xref ref-type="bibr" rid="bib52">Rodríguez-Paredes and Lyko, 2019</xref>), histidine residues also supply alternative target sites for methylation. Although this modification was previously thought to be restricted to limited proteins (<xref ref-type="bibr" rid="bib63">Webb et al., 2010</xref>), a recent comprehensive survey suggested widespread occurrence in the proteome (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Ning et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2019</xref>).</p><p>Two distinct nitrogen atoms in histidine could be methylated: the π<italic>-N</italic> position (π<italic>-N-</italic>methylhistidine or 1-methylhistidine) and the τ-<italic>N</italic> position (τ<italic>-N-</italic>methylhistidine or 3-methylhistidine) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Regarding their responsible enzymes, methyltransferase-like (METTL) 9 – a seven β-strand methyltransferase – and SET domain containing 3 (SETD3) are, as of yet, the only known mammalian protein methyltransferases for π<italic>-N</italic>-methylhistidine (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>) and τ<italic>-N-</italic>methylhistidine (<xref ref-type="bibr" rid="bib10">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Kwiatkowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Zheng et al., 2020</xref>), respectively. Nevertheless, the landscape of histidine methyltransferase-substrate pairs and, more importantly, the physiological functions of the modification have remained largely elusive.</p><p>Recent emerging studies have shown that the ribosome is a hotspot for PTM (<xref ref-type="bibr" rid="bib14">Emmott et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Simsek and Barna, 2017</xref>). This led to the idea of gene regulation through the decorated ribosomes. Indeed, PTMs on ribosomal proteins may regulate protein synthesis in specific contexts, such as a subset of transcripts (<xref ref-type="bibr" rid="bib25">Imami et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Kapasi et al., 2007</xref>; <xref ref-type="bibr" rid="bib39">Mazumder et al., 2003</xref>), the cell cycle (<xref ref-type="bibr" rid="bib25">Imami et al., 2018</xref>), stress response (<xref ref-type="bibr" rid="bib23">Higgins et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Matsuki et al., 2020</xref>), and differentiation (<xref ref-type="bibr" rid="bib64">Werner et al., 2015</xref>).</p><p>In this work, we studied the previously uncharacterized methyltransferase METTL18. Through a survey of the substrate, we found that this protein catalyzes τ<italic>-N-</italic>methylation on His245 of the ribosomal protein large subunit (RPL) 3 (uL3 as universal nomenclature). Cryo-electron microscopy (cryo-EM) suggested that τ<italic>-N-</italic>methylation interferes with the interaction of His245, which is located close to the peptidyl transferase center (PTC), with G1595 in the loop of helix 35 in 28S rRNA. Genome-wide ribosome profiling revealed that the τ<italic>-N</italic>-methylhistidine on RPL3 retards translation elongation at Tyr codons, a conclusion that was also supported by an in vitro translation assay. Quantitative proteome analysis showed that slower elongation is associated with the proper folding of synthesized proteins and thus ensures healthy proteostasis in cells; otherwise, proteins are aggregated and degraded. Our study provided an example of a modified ribosome as a nexus for the quality control of synthesized protein.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>METTL18 is a histidine τ-<italic>N</italic>-methyltransferase</title><p>To overview τ-<italic>N</italic>-histidine methylation in cells and the corresponding enzymes, we quantified τ-<italic>N</italic>-methylhistidine by mass spectrometry (MS). To distinguish the two types of histidine methylations, we performed multiple reaction monitoring (MRM) of digested amino acids to trace specific <italic>m/z</italic> transitions from the precursor (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>) (see ‘Materials and methods’ section for details). Because SETD3 modifies abundant actin proteins (<xref ref-type="bibr" rid="bib10">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Kwiatkowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Zheng et al., 2020</xref>), <italic>SETD3</italic> knockout (KO) in HEK293T cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B–E</xref>) greatly reduced τ-<italic>N</italic>-methylhistidine (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). However, a substantial fraction of τ-<italic>N</italic>-methylhistidine was left in the <italic>SETD3</italic> KO cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), suggesting the presence of other mammalian τ-<italic>N</italic>-methyltransferase(s).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>ProSeAM-SILAC identifies RPL3 as a substrate of METTL18.</title><p>(<bold>A</bold>) Multiple reaction monitoring (MRM)-based identification of τ-<italic>N</italic>-methylated histidine in bulk proteins from the indicated cell lines. Data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided). (<bold>B</bold>) Schematic representation of the ProSeAM-SILAC approach. (<bold>C</bold>) ProSeAM-labeled proteins in cell lysate with recombinant His-METTL18 protein. Biotinylated proteins were detected by streptavidin-HRP. Western blot for α-tubulin was used as a loading control. (<bold>D</bold>) Venn diagram of proteins identified in two independent ProSeAM-SILAC experiments. The reproducibly detected protein was RPL3. (<bold>E</bold>) Methylated histidine residue in ectopically expressed RPL3-FLAG was searched by liquid chromatography mass spectrometry (LC-MS/MS). (<bold>F</bold>) Quantification of methylated and unmethylated peptides (KLPRKTH) from the indicated cells. RPL3-FLAG was ectopically expressed and immunopurified for LC-MS/MS. WT, wild type; MT, Asp193Lys-Gly195Arg-Gly197Arg mutant. (<bold>G</bold>) MRM-based identification of τ-<italic>N</italic>-methylhistidine in peptides from RPL3. The τ-<italic>N</italic>-methylhistidine standard, π<italic>-N</italic>-methylhistidine standard, and RPL3-FLAG peptide (KLPRKTH) results are shown. MeHis, methylhistidine.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title></caption><media mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-data1-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Generation of <italic>SETD3</italic> and <italic>METTL18</italic> knockout (KO) cells.</title><p>(<bold>A</bold>) Chemical structure of histidine, π<italic>-N-</italic>methylhistidine, and τ<italic>-N-</italic>methylhistidine. (<bold>B</bold>) Schematic representation of guide RNAs (gRNAs) designed for CRISPR-Cas9-mediated gene KO. (<bold>C</bold>) Genomic PCR validated the partial DNA deletion in the <italic>METTL18</italic> gene locus. (<bold>D, E</bold>) Western blot of the indicated proteins to confirm the KO of <italic>SETD3</italic> and <italic>METTL18</italic> (<bold>D</bold>) and the quantification (<bold>E</bold>). α-Tubulin was probed as a loading control and for normalization. (<bold>E</bold>) Data from three replicates (points) and the mean (bar) with SD (error bar) are shown. (<bold>F</bold>) Multiple reaction monitoring (MRM)-based identification of π-<italic>N</italic>-methylated histidine in bulk proteins from the indicated cell lines. Data from three replicates (points) and the mean (bar) with SD (error bar) are shown. MeHis, methylhistidine. (<bold>G</bold>) Coomassie brilliant blue (CBB) staining of recombinant METTL18 proteins used in this study.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Full and unedited gel images corresponding to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>.</title></caption><media mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-figsupp1-data3-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig1-figsupp1-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Characterization of methylhistidine in endogenous RPL3.</title><p>(<bold>A</bold>) Sucrose density gradient for ribosomal complexes. Lysate was prepared with a buffer containing EDTA to dissociate 80S into 40S and 60S. The 60S fraction used for liquid chromatography mass spectrometry (LC-MS/MS) analysis is highlighted in gray. (<bold>B</bold>) Coomassie brilliant blue (CBB) staining of proteins in the 60S fraction in naïve and <italic>METTL18</italic> KO HEK293T cells. (<bold>C</bold>) Methylated histidine residue in endogenous RPL3 in 60S was searched by LC-MS/MS. (<bold>D</bold>) Quantification of methylated and unmethylated peptide (KLPRKTH) from endogenous RPL3 in 60S cells.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Full and unedited gel images corresponding to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement Figure 1—figure supplement 2B</xref>.</title></caption><media mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-figsupp2-data1-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig1s2sdata2"><label>Figure 1—figure supplement 2—source data 2.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig1-figsupp2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig1-figsupp2-v1.tif"/></fig></fig-group><p>An apparent candidate for the remaining τ-<italic>N</italic>-methyltransferase in <italic>SETD3</italic> KO cells was METTL18, whose yeast homolog (histidine protein methyltransferase 1 [Hpm1]) has been reported to catalyze τ-<italic>N</italic>-methylation on histidine in Rpl3 (<xref ref-type="bibr" rid="bib3">Al-Hadid et al., 2016</xref>; <xref ref-type="bibr" rid="bib2">Al-Hadid et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Webb et al., 2010</xref>). Indeed, the <italic>SETD3-METTL18</italic> double-KO (DKO) cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B–E</xref>) had even lower levels of τ-<italic>N</italic>- methylhistidine than the <italic>SETD3</italic> single-KO cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Note that we could not detect any significant alteration in π<italic>-N-</italic>methylhistidine in any cells tested in this study (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</p></sec><sec id="s2-2"><title>METTL18 catalyzes τ-<italic>N</italic>-methylation on His245 in RPL3</title><p>These observations led us to survey the methylation substrate of METTL18. For this purpose, we harnessed propargylic <italic>Se</italic>-adenosyl-<sc>l</sc>-selenomethionine (ProSeAM), an analog of <italic>S</italic>-adenosyl-<sc>l</sc>-methionine (SAM). This compound acts as a donor in the methylation reaction by the SET domain and 7-β-strand methyltransferase (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Shimazu et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Shimazu et al., 2018</xref>). Instead of a methyl moiety, a propargyl unit was added to the substrate residue, allowing biotin tagging with a click reaction (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Shimazu et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Shimazu et al., 2018</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Using ProSeAM, we performed in vitro methylation with recombinant METTL18 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>) in the lysate of <italic>METTL18</italic> KO cells and detected the ProSeAM-reacted proteins in a METTL18 protein-dependent manner (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The high background signals are likely to have originated from methyltransferases other than METTL18 in the lysate.</p><p>For the quantitative and sensitive proteomic identification of methylated protein(s), we combined this approach with stable isotope labeling using amino acids in cell culture (SILAC) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). ProSeAM was added to the cell lysates of <italic>METTL18</italic> KO cells labeled with either light or heavy isotopic amino acids. Only the extract from heavy-isotope-labeled cells was incubated with recombinant METTL18 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). After lysate pooling and streptavidin purification (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), isolated proteins were quantitatively assessed by liquid chromatography (LC)-MS/MS. Among the detected proteins, human RPL3 was the only candidate to be reproducibly identified (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>To ensure cellular histidine methylation on the protein, FLAG-tagged RPL3 was expressed in naïve HEK293T cells, immunopurified, and subjected to LC-MS/MS. This analysis identified the methylhistidine in cellular RPL3 and precisely annotated the residue at His245 (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). In stark contrast, the same experiments with <italic>METTL18</italic> KO did not detect methylated His245 (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The ectopic expression of wild-type (WT) METTL18 in the KO cells rescued the modification, whereas mutations in the potential SAM binding site (Asp193Lys-Gly195Arg-Gly197Arg), which were predicted based on lysine methyltransferase orthologs (<xref ref-type="bibr" rid="bib47">Ng et al., 2002</xref>), abolished the potential (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The same METTL18-dependent His245 methylation was also found in endogenous RPL3 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C and D</xref>), isolated in the 60S subunit (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A and B</xref>).</p><p>To distinguish the methylation forms on histidine, we applied MRM to the peptide fragments containing His245 and clearly observed that methylation occurs at the τ-<italic>N</italic> position but not at the π<italic>-N</italic> position (<xref ref-type="fig" rid="fig1">Figure 1G</xref>).</p><p>Thus, taken together, our data demonstrated that His245 of RPL3 is a METTL18 substrate for the formation of τ-<italic>N</italic>-methylhistidine in cells.</p></sec><sec id="s2-3"><title>METTL18 associates with early pre-60S</title><p>As RPL3 in crude lysate was methylated in vitro (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>), we set out to recapitulate this reaction by purified factors using <sup>14</sup>C-labeled SAM as a methyl donor. Irrespective of the human or mouse homolog, the immunopurified FLAG-tagged RPL3 proteins transiently expressed in <italic>METTL18</italic> KO cells were efficiently labeled by recombinant METTL18 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Moreover, changing His245 to Ala completely abolished the reaction, validating His245 as a methylation site.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>METTL18 associates with pre-60S.</title><p>(<bold>A</bold>) In vitro methylation assay with recombinant His-GST-METTL18 protein and <sup>14</sup>C-labeled <italic>S</italic>-adenosyl-<sc>l</sc>-methionine (SAM). Immunopurified human or mouse RPL3 expressed in <italic>METTL18</italic> knockout (KO) cells and recombinant human RPL3 expressed in bacteria were used as substrates. (<bold>B</bold>) Western blot for the indicated proteins in ribosomal complexes separated by sucrose density gradient.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Full and unedited images corresponding to <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig2-v1.tif"/></fig><p>In contrast, recombinant RPL3 expressed in bacteria was a poor substrate (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). A similar deficiency in the in vitro methylation assay by Hpm1 on solo RPL3 protein produced in bacteria was seen in yeast (<xref ref-type="bibr" rid="bib2">Al-Hadid et al., 2014</xref>). Given that RPL3 expressed in mammalian cells assembled into ribosomes but RPL3 expressed in bacteria did not, we hypothesized that METTL18 recognizes RPL3 within ribosomes or preassembled intermediates. To characterize the molecular complex associated with METTL18, we separated the ribosomal complexes through a sucrose density gradient and found that METTL18 was associated with a complex smaller than mature 60S (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Given the smaller size, we speculated that the METTL18-associating complex is pre-60S in the middle of biogenesis. Indeed, the METTL18-containing subfractions also possessed PES1 (a yeast Nop7 homolog), a ribosome biogenesis factor at an early step (<xref ref-type="bibr" rid="bib31">Kater et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Sanghai et al., 2018</xref>), and a small portion of RPL3 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). On the other hand, NMD3, an adaptor protein of the late-stage pre-60S for cytoplasmic export (<xref ref-type="bibr" rid="bib35">Ma et al., 2017</xref>; <xref ref-type="bibr" rid="bib37">Malyutin et al., 2017</xref>), was almost exclusive to the METTL18-associating pre-60S. These data suggested that RPL3, in an early intermediate complex of 60S biogenesis, is an efficient substrate for METTL18.</p></sec><sec id="s2-4"><title>Structural comparison of methylated and unmethylated His245 of RPL3 in ribosomes</title><p>The presence of METTL18 in the pre-60S complex led us to investigate the role of methylation in ribosome biogenesis. However, assessed by the bulk 28S rRNA abundance (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>) and the 60S fraction in sucrose density gradient (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B and C</xref>), no altered abundance of the 60S subunit (relative to the 40S subunit) was observed in <italic>METTL18</italic> KO cells, while the knockdown of RPL17, which is known to hamper 60S biogenesis (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>), reduced the 60S abundance in a sucrose density gradient (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D–F</xref>).</p><p>Thus, we hypothesized that RPL3 methylation may impact protein synthesis. To understand the potential role of methylation in RPL3, we reanalyzed published cryo-EM data (<xref ref-type="bibr" rid="bib49">Osterman et al., 2020</xref>) and assessed the τ-<italic>N</italic>-methyl moiety on His245 of RPL3 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), which indicated that τ-<italic>N</italic>-methylated RPL3 is a stoichiometric component of the ribosome. A similar density of methylation on the histidine of RPL3 has also been found in rabbit ribosomes (<xref ref-type="bibr" rid="bib5">Bhatt et al., 2021</xref>). On the other hand, the ribosomes isolated from <italic>METTL18</italic> KO cells lost density at the τ-<italic>N</italic> position of the His245 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The absence of methylation at the τ-<italic>N</italic> position allowed nitrogen to form hydrogen bonds with G1595 of 28S rRNA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Given that G1595 is located in the loop of helix 35, which macrolide antibiotics target in bacterial systems (<xref ref-type="bibr" rid="bib29">Kannan and Mankin, 2011</xref>), this difference in the interaction between His245 and G1595 suggests an alteration in the translation reaction.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Structural differences in ribosomes upon methylation at His245.</title><p>(<bold>A</bold>) Stick models of <sup>244</sup>GHR<sup>246</sup> of RPL3 and G1595 of the 28S rRNA of the human ribosome are shown with the cryo-electron microscopy (cryo-EM) density map around His245. The τ-<italic>N</italic>-methyl group was manually added to the original model (PDB ID: 6Y6X) (<xref ref-type="bibr" rid="bib49">Osterman et al., 2020</xref>) based on the cryo-EM density map. (<bold>B</bold>) The same model as in (<bold>A</bold>) of human ribosome from <italic>METTL18</italic> knockout (KO) cells. A hydrogen bond between His245 and G1595 is indicated with a dotted blue line.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Ribosome subunit ratio in <italic>METTL18</italic> cells.</title><p>(<bold>A</bold>) Electropherogram of ribosomal RNAs from naïve and <italic>METTL18</italic> knockout (KO) HEK293T cells. Data from two replicates are shown. (<bold>B, C</bold>) Sucrose density gradient for ribosomal complexes from naïve and <italic>METTL18</italic> KO HEK293T cells (<bold>B</bold>) and the quantification (<bold>C</bold>). The lysate was prepared with a buffer containing EDTA to dissociate 80S into 40S and 60S. In (<bold>C</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. (<bold>D</bold>) Western blot of the indicated proteins to confirm the knockdown of <italic>RPL17</italic>. β-Actin was probed for as a loading control. (<bold>E, F</bold>) Sucrose density gradient for ribosomal complexes from control siRNA (siControl) and RPL17 siRNA (siRPL17)-transfected cells (<bold>E</bold>) and the quantification (<bold>F</bold>). The lysate was prepared with a buffer containing EDTA to dissociate 80S into 40S and 60S. In (<bold>F</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>.</title></caption><media mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig3-figsupp1-data1-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig3-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Characterization of the structure of the 60S subunit from <italic>METTL18</italic> knockout (KO) cells.</title><p>(<bold>A</bold>) Representative cryo-electron microscopy (cryo-EM) micrographs of human ribosomes isolated from <italic>METTL18</italic> KO cells. (<bold>B</bold>) Flow of the cryo-EM structural analysis of the human 60S subunit from <italic>METTL18</italic> KO cells. (<bold>C</bold>) Resolution curves of the reconstituted cryo-EM structure of the human 60S subunit from <italic>METTL18</italic> KO cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig3-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Data collection, model building, refinement, and validation statistics for cryo-electron microscopy (cryo-EM) data obtained in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">Human large ribosomal subunit (obtained from <italic>METTL18</italic> KO cells) (PDB: 7F5S, EMD-31465)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Data collection and processing</bold></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Microscope</td><td align="left" valign="bottom">Tecnai Arctica</td></tr><tr><td align="left" valign="bottom"> Camera</td><td align="left" valign="bottom">K2 Summit</td></tr><tr><td align="left" valign="bottom"> Magnification</td><td align="left" valign="bottom">39,000</td></tr><tr><td align="left" valign="bottom"> Voltage (kV)</td><td align="left" valign="bottom">200</td></tr><tr><td align="left" valign="bottom"> Electron exposure (e<sup>-</sup>/Å<sup>2</sup>)</td><td align="left" valign="bottom">50</td></tr><tr><td align="left" valign="bottom"> Exposure per frame</td><td align="left" valign="bottom">1.25</td></tr><tr><td align="left" valign="bottom"> Number of frames collected</td><td align="left" valign="bottom">40</td></tr><tr><td align="left" valign="bottom"> Defocus range (μm)</td><td align="left" valign="bottom">–1.5 to –3.1</td></tr><tr><td align="left" valign="bottom"> Micrographs (no.)</td><td align="left" valign="bottom">5,517</td></tr><tr><td align="left" valign="bottom"> Pixel size (Å)</td><td align="left" valign="bottom">0.97</td></tr><tr><td align="left" valign="bottom"> 3D processing package</td><td align="left" valign="bottom">RELION-3.1</td></tr><tr><td align="left" valign="bottom"> Symmetry imposed</td><td align="left" valign="bottom">C1</td></tr><tr><td align="left" valign="bottom"> Initial particle images (no.)</td><td align="left" valign="bottom">381,227</td></tr><tr><td align="left" valign="bottom"> Final particle images (no.)</td><td align="left" valign="bottom">118,470</td></tr><tr><td align="left" valign="bottom"> Initial reference map</td><td align="left" valign="bottom">EMD-9701 (40 Å)</td></tr><tr><td align="left" valign="bottom"> <italic>RELION estimated accuracy</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Rotations (°)</td><td align="left" valign="bottom">0.162</td></tr><tr><td align="left" valign="bottom"> Translations (pixel)</td><td align="left" valign="bottom">0.287</td></tr><tr><td align="left" valign="bottom"> <italic>Map resolution</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> masked (FSC = 0.143, Å)</td><td align="left" valign="bottom">2.72</td></tr><tr><td align="left" valign="bottom"> Map sharpening B-factor</td><td align="left" valign="bottom">–63.0</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Refinement</bold></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Model refinement package</td><td align="left" valign="bottom">phenix.real_space_refine</td></tr><tr><td align="left" valign="bottom"> Initial model used</td><td align="left" valign="bottom">6QZP</td></tr><tr><td align="left" valign="bottom"> <italic>Model composition</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Chains</td><td align="left" valign="bottom">45</td></tr><tr><td align="left" valign="bottom"> Non-hydrogen atoms</td><td align="left" valign="bottom">138,634</td></tr><tr><td align="left" valign="bottom"> Residues</td><td align="left" valign="bottom">Protein: 6509; nucleotide: 3991</td></tr><tr><td align="left" valign="bottom"> Ligands</td><td align="left" valign="bottom">ZN: 5, MG: 297</td></tr><tr><td align="left" valign="bottom"> <italic>B factors</italic> (Å<sup>2</sup>)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Protein</td><td align="left" valign="bottom">62.85</td></tr><tr><td align="left" valign="bottom"> Nucleotide</td><td align="left" valign="bottom">81.15</td></tr><tr><td align="left" valign="bottom"> <italic>r.m.s. deviations</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Bond lengths (Å)</td><td align="left" valign="bottom">0.010</td></tr><tr><td align="left" valign="bottom"> Bond angles (°)</td><td align="left" valign="bottom">0.834</td></tr><tr><td align="left" valign="bottom"> <italic>Validation</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Molprobity score</td><td align="left" valign="bottom">1.92</td></tr><tr><td align="left" valign="bottom"> Clashscore</td><td align="left" valign="bottom">9.61</td></tr><tr><td align="left" valign="bottom"> Poor rotamers (%)</td><td align="left" valign="bottom">0.13</td></tr><tr><td align="left" valign="bottom"> CaBLAM outliers (%)</td><td align="left" valign="bottom">3.35</td></tr><tr><td align="left" valign="bottom"> <italic>Ramachandran plot</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Favored (%)</td><td align="left" valign="bottom">93.79</td></tr><tr><td align="left" valign="bottom"> Allowed (%)</td><td align="left" valign="bottom">6.08</td></tr><tr><td align="left" valign="bottom"> Disallowed (%)</td><td align="left" valign="bottom">0.12</td></tr><tr><td align="left" valign="bottom">Map CC (CCmask)</td><td align="left" valign="bottom">0.90</td></tr></tbody></table></table-wrap></sec><sec id="s2-5"><title>Methylation of His245 of RPL3 slows ribosome traverse at Tyr codons</title><p>To investigate the impacts of the modification on protein synthesis, we assessed global translation in <italic>METTL18</italic> KO cells. However, we could not detect a significant difference in overall translation probed by polysome formation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>), whereas RPL17 knockdown reduced the polysome (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>). Similarly, we could not observe a significant alteration in nascent peptides labeled with <italic>O</italic>-propargyl-puromycin (OP-puro) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>).</p><p>Nonetheless, we investigated the implications of RPL3 methylation defects across the transcriptome by ribosome profiling (<xref ref-type="bibr" rid="bib26">Ingolia et al., 2009</xref>; <xref ref-type="bibr" rid="bib27">Iwasaki and Ingolia, 2017</xref>). Strikingly, we found increased translation elongation of Tyr codons in <italic>METTL18</italic> KO cells; ribosome occupancy on Tyr codons at the A-site was selectively reduced in the mutant cells (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). This trend in ribosome occupancy was not observed at the P and E sites (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>). To evaluate the amino acid context associated with the high elongation rate, we surveyed the motifs around the A-site with reduced ribosome occupancy by METTL18 depletion (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) and analyzed the enriched/depleted sequence in the group (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Remarkably, Tyr at the A-site was the predominant determinant for fast elongation in <italic>METTL18</italic> KO cells (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Ribosome profiling reveals Tyr codon-specific translation retardation by RPL3 methylation.</title><p>(<bold>A</bold>) Ribosome occupancy at A-site codons in naïve and <italic>METTL18</italic> knockout (KO) HEK293T cells. Data were aggregated into codons with each amino acid species. (<bold>B</bold>) Ribosome occupancy changes at A-site codons caused by <italic>METTL18</italic> KO. (<bold>C</bold>) Histogram of ribosome occupancy changes in <italic>METTL18</italic> KO cells across motifs around A-site codons (seven amino acid motifs). Cyan: motifs with reduced ribosome occupancy (defined by ≤ mean – 2 SD). (<bold>D</bold>) Amino acid motifs associated with reduced ribosome occupancy in <italic>METTL18</italic> KO cells (defined in <bold>C</bold>) are shown relative to the A-site (at the 0 position). (<bold>E</bold>) Distribution of footprint length in naïve and <italic>METTL18</italic> KO HEK293T cells. (<bold>F</bold>) Ribosome occupancy changes on Tyr codons by <italic>METTL18</italic> KO along all, long (28–33 nt), and short (20–24 nt) footprints. Significance was determined by the Mann–Whitney <italic>U</italic>-test. (<bold>G</bold>) The recovery of long footprint reduction in <italic>METTL18</italic> KO cells by ectopic expression of METTL18 protein. Significance was determined by the Mann–Whitney <italic>U</italic>-test. (<bold>H</bold>) Changes in ribosome occupancy on Tyr codons by <italic>METTL18</italic> KO in HAP1 cells along long (28–33 nt) footprints. Del., deletion. In (<bold>A–C</bold>) and (<bold>E–H</bold>), the means of two independent experiments are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Basal translation activity in <italic>METTL18</italic> cells.</title><p>(<bold>A, B</bold>) Sucrose density gradient for ribosomal complexes from naïve and <italic>METTL18</italic> knockout (KO) HEK293T cells (<bold>A</bold>) and the quantification (<bold>B</bold>). The 80S ribosome and polysomes were stabilized by Mg ion and cycloheximide. In (<bold>B</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. (<bold>C, D</bold>) Sucrose density gradient for ribosomal complexes from control siRNA (siControl)- and RPL17 siRNA (siRPL17)-transfected cells (<bold>C</bold>) and the quantification (<bold>D</bold>). 80S and polysomes were stabilized by Mg ion and cycloheximide. In (<bold>D</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided). (<bold>E</bold>) Newly synthesized proteins in naïve and <italic>METTL18</italic> KO HEK293T cells were labeled with OP-puro and then conjugated with infrared 800 (IR800) dye with a click reaction. The signal was normalized to total proteins stained with Coomassie brilliant blue (CBB). Data from three replicates (points) and the mean (bar) with SD (error bar) are shown.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B, D, and E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Characterization of ribosome occupancy monitored by ribosome profiling.</title><p>(<bold>A, B</bold>) Ribosome occupancy at P-site (<bold>A</bold>) and E-site (<bold>B</bold>) codons. Data were aggregated into codons with each amino acid species. The means of two independent experiments are shown. (<bold>C, D</bold>) Northern blot for tRNA<sup>Tyr</sup><sub>GUA</sub> (<bold>C</bold>) and its quantification (<bold>D</bold>). U6 snRNA was used as loading control. In (<bold>D</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided). (<bold>E, F</bold>) Same as (<bold>C</bold>) and (<bold>F</bold>) but for tRNA<sup>Leu</sup><sub>HAG</sub>. In (<bold>F</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. H stands for A, C, or U. (<bold>G</bold>) Schematic representation of mutations in <italic>METTL18</italic> KO HAP1 cells. Del., deletion.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig4-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig4-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata3"><label>Figure 4—figure supplement 2—source data 3.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D and F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig4-figsupp2-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig4-figsupp2-v1.tif"/></fig></fig-group><p>The smoother elongation may be caused by increased tRNA abundance. However, tRNA<sup>Tyr</sup><sub>GUA</sub>, which decodes both UAU and UAC codons, was noticeably reduced by METTL18 depletion (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C and D</xref>). On the other hand, the abundance control tRNA<sup>Leu</sup><sub>HAG</sub> was not altered (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E and F</xref>). Thus, tRNA abundance did not explain the reduced footprints on Tyr codons.</p><p>Further ribosome profiling data analysis supported that the accommodation of tRNA at the A-site may not explain the modulation of elongation by RPL3 methylation. Ribosome footprints possess two distinct populations of different lengths (short, peaked at ~22 nt; long, peaked at ~29 nt), reflecting the presence of A-site tRNA (<xref ref-type="bibr" rid="bib34">Lareau et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Wu et al., 2019</xref>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>). Since A-site tRNA-free ribosomes are more susceptible to RNase treatment at the 3′ end, the trimmed short footprints represent nonrotated ribosomes waiting for A-site codon decoding by tRNA. On the other hand, long footprints originate from ribosomes accommodated with A-site tRNA in the middle of the peptidyl transfer reaction or subsequent subunit rotation (<xref ref-type="bibr" rid="bib34">Lareau et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Wu et al., 2019</xref>). The reduced footprints on Tyr codons in <italic>METTL18</italic> KO cells were more prominent in long footprints than short footprints (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Moreover, the long footprints were recovered by ectopic expression of METTL18 protein (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). These data suggested that the process or processes downstream of codon decoding are promoted in KO cells. This observation was reasonable, given the relatively long distance between the τ-<italic>N</italic>-methylated histidine and the mRNA codon.</p><p>To test the cell-type specificity, we further extended our ribosome profiling experiments in HAP1 cells, which originate from chronic myelogenous leukemia. We investigated ribosome footprints on the Tyr codons in three independent <italic>METTL18</italic> KO cell lines (1-nt, 2-nt, and 4-nt deletions) that should lead to truncated proteins (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2G</xref>) and observed the reduction of ribosome occupancies on the codons in those cell lines as well (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). These data suggested consistent effects of RPL3 methylation on elongation irrespective of cell type.</p></sec><sec id="s2-6"><title>Ribosomes deficient for RPL3 methylation exhibit higher processivity on Tyr codons in vitro</title><p>To further assess the effect of RPL3 methylation on Tyr codon elongation, we combined hybrid in vitro translation (<xref ref-type="bibr" rid="bib16">Erales et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Panthu et al., 2015</xref>) with the <italic>Renilla</italic>-firefly luciferase fusion reporter system (<xref ref-type="bibr" rid="bib32">Kisly et al., 2021</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). In this setup, we purified ribosomes from HEK293T (naïve or <italic>METTL18</italic> KO) cells, added them to ribosome-depleted rabbit reticulocyte lysate (RRL), and then conducted an in vitro translation assay (i.e., hybrid translation) (<xref ref-type="bibr" rid="bib16">Erales et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Panthu et al., 2015</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Indeed, we observed that removal of the ribosomes from RRL decreased protein synthesis in vitro and that complementation with ribosomes from HEK293T cells recovered the activity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Ribosome without RPL3 methylation shows higher processivity on Tyr codons in vitro.</title><p>(<bold>A</bold>) Schematic representation of the hybrid translation system and the processivity reporter. (<bold>B</bold>) The box plot for the relative ratio of Slope<sub>Fluc</sub> to Slop<sub>Rluc</sub> for the reporter with Tyr repeat insertion. Data from seven replicates (points) are shown. Significance was determined by Brunner–Munzel test (unpaired, two-sided).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Characterization of hybrid translation system and <italic>Renilla</italic>-firefly fused reporter.</title><p>(<bold>A</bold>) In vitro translation from firefly luciferase was conducted in the indicated materials. Data from three replicates (points) and the mean (bar) with SD (error bar) are shown. RRL, rabbit reticulocyte lysate. (<bold>B</bold>) The box plot for the relative ratio of Slope<sub>Fluc</sub> to Slop<sub>Rluc</sub> for the reporters with and without Tyr repeat insertion. Data from three replicates for no insertion reporter and seven replicates for Tyr repeat-inserted reporter (points) are shown. Significance was determined by the Student’s <italic>t</italic>-test (unpaired, two-sided).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To test the effect on Tyr codon elongation, we harnessed the fusion of <italic>Renilla</italic> and firefly luciferases; this system makes it possible to detect the delay/promotion of downstream firefly luciferase synthesis compared to upstream <italic>Renilla</italic> luciferase and thus to focus on the effect of the sequence inserted between the two luciferases on elongation (<xref ref-type="bibr" rid="bib32">Kisly et al., 2021</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). For better detection of the effects on Tyr codons, we used a repeat of the codon (×39; the number was due to cloning constraints). We note that the insertion of Tyr codon repeats reduced the elongation rate (or processivity), as we observed the reduced slope of the downstream Fluc synthesis (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>).</p><p>Then, we coupled the in vitro translation system and the reporter. We observed that RPL3 methylation-deficient ribosomes exhibited faster elongation on Tyr repeats than ones from naïve cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><p>These in cell and in vitro data together indicated that RPL3 methylation mediated a slowing of translation elongation on the Tyr codons.</p></sec><sec id="s2-7"><title>RPL3 histidine methylation ensures the proper proteostasis</title><p>Ribosome traverse along the mRNA determines the quality of protein synthesized (<xref ref-type="bibr" rid="bib7">Cassaignau et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Collart and Weiss, 2019</xref>; <xref ref-type="bibr" rid="bib59">Stein and Frydman, 2019</xref>). Slowdown of ribosome elongation is advantageous since it allows the duration of nascent protein folding before completion of protein synthesis. Therefore, we reasoned that translation elongation slowdown at Tyr codons by RPL3 methylation facilitates protein folding on ribosomes and maintains proper homeostasis of the proteome.</p><p>To test this possibility, we employed an aggregation-prone firefly luciferase (Fluc) reporter (Arg188Gln-Arg261Gln double mutant or DM) fused to enhanced green fluorescent protein (EGFP) (<xref ref-type="bibr" rid="bib20">Gupta et al., 2011</xref>). Since this engineered protein necessitates chaperones to fold properly, the reduced pool of available chaperones (i.e., proteotoxicity) leads to aggregation puncta of the reporter protein in cells. Indeed, METTL18 depletion induced the aggregation of FlucDM but not Fluc WT reporter (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). As shown by the recovery of protein abundance by treatment with the proteasome inhibitor MG132 (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), FlucDM protein was synthesized in <italic>METTL18</italic> KO cells of low quality and subjected to degradation.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>METTL18 deletion leads to cellular proteotoxicity.</title><p>(<bold>A</bold>) Microscopic images of FlucWT-EGFP or FlucDM-EGFP in naïve and <italic>METTL18</italic> knockout (KO) HEK293T cells. Arrowhead, protein aggregation; scale bar, 10 μm. (<bold>B</bold>) Quantification of cells with Fluc-EGFP aggregates. Data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided). (<bold>C</bold>) Western blot for FlucDM-EGFP (probed by anti-GFP antibody) expressed in naïve and <italic>METTL18</italic> KO HEK293T cells treated with MG132 (0.25 μM for 24 hr). β-Actin was probed as a loading control.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Full and unedited images corresponding to <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-72780-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig6-data2-v1.tif"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig6-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig6-v1.tif"/></fig><p>Then, we explored the proteome, the quality of which was assisted by RPL3 histidine methylation. For this purpose, we surveyed the proteins aggregated in <italic>METTL18</italic> KO cells by SILAC (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We observed that a subset of proteins were enriched in precipitates of <italic>METTL18</italic> KO cell lysates (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). This subgroup significantly accumulated Tyr-rich proteins (defined as proteins possessing 30 Tyr or more) (hypergeometric test, p=0.0068) (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The high probability of protein precipitates could not be explained by the increased net protein synthesis measured by ribosome profiling (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). More generally, Tyr-rich proteins were more prone to precipitate upon the deletion of METTL18 (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>) than proteins rich in other amino acids (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Thus, proteomic analysis of cellular precipitates revealed that the modulation of Tyr-specific translation elongation by RPL3 methylation confers proteome integrity.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>METTL18 deletion aggregates Tyr-rich proteins.</title><p>(<bold>A</bold>) Schematic representation of SILAC-MS for precipitated proteins. (<bold>B</bold>) Volcano plot for precipitated proteins in <italic>METTL18</italic> knockout (KO) cells, assessed by SILAC-MS (n = 2). Tyr-rich proteins were defined as proteins with 30 or more Tyr residues. (<bold>C</bold>) Amino acids associated with protein precipitation in <italic>METTL18</italic> KO cells. Precipitated proteins enriched with each amino acid were compared to the total precipitated proteome. The mean fold change and the significance (Mann–Whitney <italic>U</italic>-test) were plotted. (<bold>D</bold>) Metagene plot for aggregation percentage, calculated with TANGO (<xref ref-type="bibr" rid="bib17">Fernandez-Escamilla et al., 2004</xref>), around Tyr codons of precipitated proteins in <italic>METTL18</italic> KO cells (defined in <bold>B</bold>). (<bold>E</bold>) Distribution (at the A-site) of ribosome footprint occupancy (the mean of two independent experiments) along the MACROH2A1 gene in naïve (gray) and <italic>METTL18</italic> KO (magenta) HEK293T cells, depicted with the aggregation percentage (light blue) calculated by TANGO (<xref ref-type="bibr" rid="bib17">Fernandez-Escamilla et al., 2004</xref>). Tyr codon positions are highlighted with arrows.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Characterization of precipitated proteins identified by SILAC-MS.</title><p>(<bold>A</bold>) Comparison of fold change in protein precipitates (n = 2) assessed by SILAC and that in ribosome profiling by METTL18 depletion. (<bold>B</bold>) Cumulative distribution of Tyr-rich proteins along the fold change in protein precipitates by METTL18 depletion. Significance was calculated by the Mann–Whitney <italic>U</italic>-test. (<bold>C, D</bold>) Distribution (at the A-site) of ribosome footprint occupancy (the mean of two independent experiments) along the MACROH2A1 gene in naïve (gray) and <italic>METTL18</italic> KO (magenta) HEK293T cells, depicted with the aggregation percentage (light blue) calculated with TANGO (<xref ref-type="bibr" rid="bib17">Fernandez-Escamilla et al., 2004</xref>). Tyr codon positions are highlighted with arrows. Data on the entire CDS (<bold>C</bold>) and the 30–60 amino acid region (<bold>D</bold>) are depicted.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig7-figsupp1-v1.tif"/></fig></fig-group><p>These data led us to further investigate the properties of the proteome associated with Tyr. Here, we surveyed the aggregation propensity of the precipitated proteins by TANGO, which is based on statistical mechanics (<xref ref-type="bibr" rid="bib17">Fernandez-Escamilla et al., 2004</xref>). Strikingly, metagene analysis showed prominent enrichment of the TANGO-predicted aggregation propensity around the Tyr codons (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). As exemplified in the MACROH2A1 protein, the subpart of the aggregation-prone region in this protein was found on Tyr with reduced ribosome occupancies in <italic>METTL18</italic> KO cells (<xref ref-type="fig" rid="fig7">Figure 7E</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C and D</xref>).</p><p>Ultimately, the low-quality protein synthesized by RPL3-unmethylated ribosomes may serve as a substrate for proteasomes. To assess the fraction of proteins degraded by proteasome, we conducted SILAC analysis of the total proteome in <italic>METTL18</italic> KO cells treated with MG132, a proteasome inhibitor (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Indeed, this approach revealed a subset of more efficiently degraded proteins in <italic>METTL18</italic> KO cells (<xref ref-type="fig" rid="fig8">Figure 8B</xref>); this group of proteins tended to be reduced in <italic>METTL18</italic> KO cells and recovered by MG132 treatment. Moreover, this subset of proteins included Tyr-rich proteins (<xref ref-type="fig" rid="fig8">Figure 8C</xref>), which was congruent with the enhanced elongation observed in ribosome profiling.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>METTL18 deletion degrades Tyr-rich proteins by proteasome.</title><p>(<bold>A</bold>) Schematic representation of SILAC-MS for total proteins. (<bold>B, C</bold>) Cellular protein abundance changes in <italic>METTL18</italic> knockout (KO) cells with the treatment of proteasome inhibitor MG132 and the control DMSO, assessed by SILAC-MS (n = 2). The relative abundance in <italic>METTL18</italic> KO HEK293T cells compared to naïve HEK293T cells is calculated. Data with DMSO or MG132 treatment (<bold>B</bold>) and fold enrichment (MG132 compared to DMSO) (<bold>C</bold>) are shown ranked by the fold enrichment in (<bold>C</bold>). Proteins with 1.5 or higher enrichment by MG132 treatment are highlighted. Tyr-rich proteins are defined as proteins with 30 or more Tyr residues.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig8-v1.tif"/></fig><p>The relationships among the aggregation-prone character of the protein, the cellular protein precipitates, increased proteasomal substrates, and reduced ribosome occupancy indicates that Tyr translation modulated by RPL3-methylated ribosomes is associated with the quality of the synthesized proteins, preventing unwanted protein aggregation (<xref ref-type="fig" rid="fig9">Figure 9</xref>).</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Schematic representation of METTL18-mediated control of translation and proteostasis.</title><p>METTL18 adds a methyl moiety at the τ-<italic>N</italic> position of His245 in RPL3 in the form of an early 60S biogenesis intermediate. Methylated ribosomes slow elongation at Tyr codons and extend the duration of nascent peptide folding, ensuring proteostatic integrity. Without RPL3 methylation, the accumulation of unfolded and ultimately aggregated proteins in cells was induced.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig9-v1.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Comparison of the structure of the early and late pre-60S as a possible RPL3 methylation target.</title><p>(<bold>A, B</bold>) Structures of early (state B, PDB 6EM4:) and late (state D, PDB: 6EM5) pre-60S (<xref ref-type="bibr" rid="bib31">Kater et al., 2017</xref>). A possible region of the protein fragment containing His245 in RPL3 is highlighted in a dashed circle. RPL3, magenta; assembly factor, light blue; ribosomal proteins, light gray; rRNA, dark gray. (<bold>C, D</bold>) Metagene analysis of ribosome footprints around the stop codon. A-site potion of footprints is depicted. In (<bold>D</bold>), a zoomed-in view of the plot is shown. The mean of two independent experiments is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig9-figsupp1-v1.tif"/></fig><fig id="fig9s2" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 2.</label><caption><title>The impacts of METTL18 deletion in HAP1 cells on ribosomal complex formation.</title><p>(<bold>A, B</bold>) Sucrose density gradient for ribosomal complexes from naïve and <italic>METTL18</italic> knockout (KO) (2-nt del.) HAP1 cells (<bold>A</bold>) and the quantification (<bold>B</bold>). 80S and polysomes were stabilized by Mg ion and cycloheximide. In (<bold>B</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. Significance was determined by Student’s <italic>t</italic>-test (unpaired, two-sided). (<bold>C, D</bold>) Sucrose density gradient for ribosomal complexes from naïve and <italic>METTL18</italic> KO (2-nt del.) HAP1 cells (<bold>C</bold>) and the quantification (<bold>D</bold>). The lysate was prepared with a buffer containing EDTA to dissociate 80S into 40S and 60S. In (<bold>D</bold>), data from three replicates (points) and the mean (bar) with SD (error bar) are shown. (<bold>E</bold>) Quantification of ribosomal RNAs from naïve and <italic>METTL18</italic> KO (2-nt del.) HAP1 cells by fragment analyzer. Data from three replicates (points) and the mean (bar) with SD (error bar) are shown.</p><p><supplementary-material id="fig9s2sdata1"><label>Figure 9—figure supplement 2—source data 1.</label><caption><title>Primary data for graphs in <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2B, D, and E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-72780-fig9-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-fig9-figsupp2-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In addition to SETD3 (<xref ref-type="bibr" rid="bib10">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Kwiatkowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Zheng et al., 2020</xref>), METTL18 provides a second example of τ-<italic>N</italic>-methyltransferase. Whereas τ-<italic>N</italic>-methylation at the equivalent residue (His243) in yeast Rpl3 has been indirectly demonstrated (<xref ref-type="bibr" rid="bib63">Webb et al., 2010</xref>), this study provided solid evidence (such as MS and cryo-EM) of the modification on the homolog in humans.</p><p>Similar to prior yeast work (<xref ref-type="bibr" rid="bib2">Al-Hadid et al., 2014</xref>), human RPL3 alone could not be methylated by METTL18. Rather, RPL3 was most likely to be modified in the early 60S biogenesis intermediate complex. This suggests that METTL18 recognizes a unique interface formed by RPL3 and other ribosome proteins and/or assembly factors. In the recent structural studies on pre-60 assembly intermediates (<xref ref-type="bibr" rid="bib31">Kater et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Sanghai et al., 2018</xref>), His245 of RPL3 in the early pre-60S in state B (<xref ref-type="bibr" rid="bib31">Kater et al., 2017</xref>) is exposed to solvent (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A</xref>), possibly enabling access to METTL18, although His245 per se was not visible in the structure because of flexibility. In contrast, ribosomal proteins and rRNAs in the later stage of 60S biogenesis (at state D) (<xref ref-type="bibr" rid="bib31">Kater et al., 2017</xref>) fill the corresponding space (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1B</xref>). Thus, histidine methylation by METTL18 should be restricted to specific timing of the macromolecule assembly.</p><p>In the course of this work, a paper from Falnes and coworkers was published and reached a similar conclusion regarding the methylation site (His245 in RPL3) and the methylation type (τ-<italic>N</italic> position) mediated by human METTL18 (<xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>). Although the earlier report showed that recombinant METTL18 protein methylated isolated ribosomes from <italic>METTL18</italic> KO, the authors also observed that METTL18 localized in nucleoli (<xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>) where ribosomes are still under assembly. These data could be interpreted to show that the purified ribosome may consist of contaminated pre-60S, and this fraction was an efficient substrate of METTL18.</p><p>The impact of METTL18 loss on translation found in this study differed from that in the earlier report (<xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>). In the earlier report, ribosome profiling in <italic>METTL18</italic> KO HAP1 cells revealed widespread effects of translation elongation, exemplified by slowdown of the GAA codon (<xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>). In contrast, the same experiment in this work with HEK293T and HAP1 (including the same cell line [2-nt del.] used in <xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>) showed that <italic>METTL18</italic> KO enhanced ribosome traversal on Tyr codons (<xref ref-type="fig" rid="fig4">Figure 4</xref>). We did not have any information on how to reconcile this inconsistency in ribosome profiling data. At least, as reported previously (<xref ref-type="bibr" rid="bib36">Małecki et al., 2021</xref>), we have made a similar observation in the bulk ribosomal complex abundance in the <italic>METTL18</italic> KO HAP1 cell line (2-nt del.); reduced polysomes (<xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2A and B</xref>) and unaltered 40S and 60S (<xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2C–E</xref>). The effect of RPL3 methylation on translation elongation could be dynamic and dependent on cellular status affected by circumstances (e.g., culturing conditions). Future studies across diverse tissues and cellar status will provide a global look at the condition-dependent effects of the ribosome protein methylation.</p><p>The modification-mediated ribosome slowdown revealed in this study provides a unique example of translational control since modification in general often offers a smooth translation, as exemplified in tRNA modifications (<xref ref-type="bibr" rid="bib46">Nedialkova and Leidel, 2015</xref>; <xref ref-type="bibr" rid="bib61">Tuorto et al., 2018</xref>). The exact mechanism of how His245 methylation in RPL3 leads to Tyr-specific elongation retardation remains elusive. In bacteria, the loop of helix 35, where unmethylated His245 interacts, was heavily modified (<xref ref-type="bibr" rid="bib29">Kannan and Mankin, 2011</xref>), although the role of rRNA modification has been unclear. Eukaryotic RPL3 may functionally replace RNA modification by histidine methylation. From another viewpoint, His245 is located in the ‘basic thumb’ region (Arg234-Arg246), which bridges the interaction of 28S rRNA helices (H61, H73, and H90) and facilitates the formation of a so-called ‘aminoacyl-tRNA accommodation corridor’ (<xref ref-type="bibr" rid="bib41">Meskauskas and Dinman, 2010</xref>). Thus, the methylation of His245 may allosterically alter the dynamic character of the aminoacyl-tRNA accommodation corridor to restrict the movement of charged Tyr on tRNA. Indeed, conformational changes in the aminoacyl-tRNA accommodation corridor were suggested by molecular dynamics simulation (<xref ref-type="bibr" rid="bib18">Gulay et al., 2017</xref>).</p><p>We also did not exclude the possibility that this modification may impact other processes of translation. Indeed, an earlier report in yeast suggested that Hpm1 (a homolog of METTL18) deletion decreased the fidelity of translation, inducing stop codon readthrough (<xref ref-type="bibr" rid="bib3">Al-Hadid et al., 2016</xref>; <xref ref-type="bibr" rid="bib2">Al-Hadid et al., 2014</xref>). However, our ribosome profiling data in HEK293T cells did not show any increase in ribosome footprints in the 3′ UTR (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1C and D</xref>) that could be accumulated by the stop codon readthrough (<xref ref-type="bibr" rid="bib4">Arribere et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Dunn et al., 2013</xref>).</p><p>Although ribosome traversal along the CDS is generally defined by the decoding rate in bacteria (<xref ref-type="bibr" rid="bib43">Mohammad et al., 2019</xref>) and yeasts (<xref ref-type="bibr" rid="bib24">Hussmann et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Wu et al., 2019</xref>), the codon/amino acid-specific effects of RPL3 histidine methylation in humans suggest that the landscape is more complex in higher eukaryotes. Indeed, ribosome occupancy in mammals is poorly predicted by tRNA abundance in cells (<xref ref-type="bibr" rid="bib21">Han et al., 2020</xref>). Thus, it is not surprising that a wide array of ribosome modifications, including RPL3 histidine modification, ultimately define the speed of ribosome movement and thus the quality of protein synthesized in cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Plasmid construction</title><sec id="s4-1-1"><title>PX330-B/B-gMETTL18</title><p>To express two guide RNAs targeting upstream and downstream regions of exon 2 of the <italic>METTL18</italic> gene, DNA fragments containing <named-content content-type="sequence">5′-TCTCTTTAGCAGCTTATACA-3</named-content>′ and <named-content content-type="sequence">5′-GGTTGTGGATCAGGTTTACT-3′</named-content> were cloned into PX330-B/B (<xref ref-type="bibr" rid="bib69">Yamazaki et al., 2018</xref>) via the BbsI and BsaI sites, respectively.</p></sec><sec id="s4-1-2"><title>pL-CRISPR.EFS.tRFP-gSETD3</title><p>To express a guide RNA targeting exon 6 of the <italic>SETD3</italic> gene, a DNA fragment containing <named-content content-type="sequence">5′-AGCCATGGGAAACATCGCAC-3′</named-content> was cloned into pL-CRISPR.EFS.tRFP (Addgene#57819; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:57819; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_57819">Addgene_57819</ext-link>) (<xref ref-type="bibr" rid="bib22">Heckl et al., 2014</xref>).</p></sec><sec id="s4-1-3"><title>pET19b-mMETTL18</title><p>To express N-terminally His-tagged full-length mouse METTL18, cDNA was PCR-amplified from a FANTOM clone (AK139786) and cloned into NdeI and XhoI sites of the pET19b vector (Novagen).</p></sec><sec id="s4-1-4"><title>pCold-GST-mMETTL18</title><p>To express N-terminally His- and GST-tagged full-length mouse METTL18, the PCR-amplified fragment was cloned into the NdeI and XhoI sites of the pCold-GST vector (TaKaRa).</p></sec><sec id="s4-1-5"><title>pcDNA3-hRPL3-FLAG (WT and His245Ala) and pcDNA3-mRPL3-FLAG (WT and His245Ala)</title><p>To express C-terminally FLAG-tagged mouse and human RPL3, each cDNA fragment was amplified from the mouse cDNA and HEK293T cDNA libraries and cloned into EcoRI and NotI sites of the pcDNA3 vector (Invitrogen) with a C-terminal FLAG-tag sequence. To generate His245Ala mutants, the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) was used.</p></sec><sec id="s4-1-6"><title>pQCXIP-hMETTL18-HA and hMETTL18-Asp193Lys-Gly195Arg-Gly197Arg-HA</title><p>For retrovirus expression, cDNA fragment of human METTL18 with a C-terminal HA sequence was cloned into AgeI and EcoRI sites of the pQCXIP vector (Clontech). To generate hMETTL18-Asp193Lys-Gly195Arg-Gly197Arg-HA, the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) was used.</p></sec><sec id="s4-1-7"><title>psiCHECK2-Y0× and Y39×</title><p>To generate the psiCHECK2-Y0× reporter, the intergenic region between Rluc and Fluc was excluded by inverse PCR. The plasmid encodes the ORF for the Rluc-Fluc fusion. To generate the psiCHECK2-Y39× reporter, 39 repeats of the TAC sequence were inserted between Rluc and Fluc of psiCHECK2-Y0×.</p></sec></sec><sec id="s4-2"><title>Cell lines: HEK293T</title><p>HEK293T KO cell lines were generated by the CRISPR-Cas9 system. All cell lines in the laboratory were routinely tested for <italic>Mycoplasma</italic> contamination with the MycoAlert Mycoplasma Detection Kit (LONZA) and confirmed negative.</p><sec id="s4-2-1"><title><italic>METTL18</italic> KO cells</title><p>PX330-B/B-gMETTL18, which expresses hCas9 and two guide RNAs designed to induce large deletions in exon 2, and pEGFP-C1 (Clontech) were cotransfected into HEK293T cells. After 2 days of incubation, individual GFP-positive cells were sorted into 96-well plates. The clonal cell lines were screened by genomic PCR with the primers <named-content content-type="sequence">5′-GGACTTTATGTTTGTCCAGGTGG-3′</named-content> and <named-content content-type="sequence">5′-TGGGTTGTAAATGGTTTCTGAGG-3′</named-content>. e-Myco VALiD (LiliF) confirmed that the cells were negative for <italic>Mycoplasma</italic>.</p></sec><sec id="s4-2-2"><title><italic>METTL18</italic> KO cells with stable METTL18 expression</title><p>Retrovirus packaging cells were transfected with pQCXIP-hMETTL18-HA, pQCXIP-hMETTL18-Asp193Lys-Gly195Arg-Gly197Arg-HA, or the pQCXIP empty vector (as a negative control) using PEI transfection reagent (Polysciences) and cultured for 24 hr. Then, <italic>METTL18</italic> KO cells were inoculated with the virus-containing culture supernatant and 4 μg/ml of polybrene. At 24 hr post-infection, cells were selected with 1 μg/ml puromycin and cultured for additional 2 weeks. e-Myco VALiD (LiliF) confirmed that the cells were negative for <italic>Mycoplasma</italic>.</p></sec><sec id="s4-2-3"><title>SETD3 KO and SETD3-METTL18 DKO cells</title><p>pL-CRISPR.EFS.tRFP-gSETD3, which expressed a guide RNA designed to induce small insertion or deletion (InDel), was transfected into HEK293T cells or <italic>METTL18</italic> KO cells. After 2 days of incubation, individual RFP-positive cells were sorted into 96-well plates. The clonal cell lines were further screened by Western blot for SETD3 protein.</p></sec><sec id="s4-2-4"><title>Cell lines: HAP1</title><p>HAP1 cells, including naïve cells (C631) and <italic>METTL18</italic> KO cells (1-nt del., HZGHC000541c009; 2-nt del., HZGHC000541c002; and 4-nt del., HZGHC000541c012), were purchased from Horizon Discovery. e-Myco VALiD (LiliF) confirmed that the cells were negative for <italic>Mycoplasma</italic>.</p></sec></sec><sec id="s4-3"><title>Recombinant protein purification</title><sec id="s4-3-1"><title><italic>Salmonella</italic> MTAN, His-METTL18, and His-GST-METTL18</title><p>The BL21 (pLysS) strain transformed with <italic>Salmonella</italic> MTAN (a gift from Vern Schramm [Addgene plasmid #64041; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:64041; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_64041">Addgene_64041</ext-link>]), pET19b-mMETTL18, or pCold-GST-mMETTL18 was cultured in 2× YT medium with 100 µg/ml ampicillin and 0.2 mM isopropyl β-<sc>d</sc>-1-thiogalactopyranoside (IPTG) for 18 hr at 16°C. The pelleted cells were lysed with 1× PBS with 0.5% NP-40 by sonication with a sonic homogenizer (Branson Ultrasonics, Sonifier S-250D) for 5 min on ice. After centrifugation at 15,000 × <italic>g</italic> for 10 min, the cleared cell extract was incubated with Ni-NTA Agarose (QIAGEN) or Glutathione Sepharose 4B (Cytiva) for 1 hr at 4°C with gentle agitation. The beads were washed five times with His wash buffer (50 mM Tris-HCl pH 7.4 and 25 mM imidazole) or GST wash buffer (1× phosphate-buffered saline [PBS]). Then, proteins were eluted with His elution buffer (50 mM Tris-HCl pH 7.4 and 250 mM imidazole) or GST elution buffer (50 mM Tris-HCl pH 8.0 and 50 mM glutathione). The purified proteins were dialyzed with dialysis buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.2 mM dithiothreitol [DTT], and 10% glycerol) using Slide-A-Lyzer Dialysis Cassettes (MWCO 10 kDa, Thermo Fisher Scientific) or Amicon Ultra (MWCO 10 kDa, Merck Millipore). The protein concentration was measured using the Bradford Protein Assay Kit (Bio-Rad).</p></sec></sec><sec id="s4-4"><title>Western blot</title><p>Anti-α-tubulin (Sigma-Aldrich, clone B-5-1-2, 1:1000), anti-METTL18 (Proteintech Group, 25553-1-AP), anti-SETD3 (Abcam, ab174662, 1:1000), anti-RPL3 (Proteintech Group, 66130-1-lg and 11005-1-AP, 1:1000), anti-PES1 (Abcam, ab252849, 1:1000), anti-NMD3 (Abcam, ab170898, 1:1000), anti-HA (Medical &amp; Biological Laboratories [MBL], M180-3, 1:1000), anti-GFP (Abcam, ab6556, 1:1000), anti-RPL17 (Proteintech Group, 14121–1-AP, 1:1000), and anti-β-actin (MBL, M177-3, 1:1000) primary antibodies were used.</p><p>For <xref ref-type="fig" rid="fig1">Figures 1C</xref> and <xref ref-type="fig" rid="fig2">2A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>, anti-mouse IgG, HRP-Linked Whole Ab Sheep (Cytiva, NA931V, 1:5000) and anti-rabbit IgG, HRP-Linked Whole Ab Donkey (Cytiva, NA934V, 1:5000) secondary antibodies were used. The chemiluminescence was raised with a Western Lightning Plus-ECL Kit (PerkinElmer) according to the manufacturer’s protocol and detected with X-ray film (FUJIFILM, RX-U). For biotinylated proteins, high-sensitivity streptavidin-HRP (Thermo Fisher Scientific, 21130) was used.</p><p>To generate <xref ref-type="fig" rid="fig2">Figures 2B</xref> and <xref ref-type="fig" rid="fig5">5C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>, IRDye680- or IRDye800CW-conjugated secondary antibodies (LI-COR Biosciences, 925-68070/71 and 926-32210/11/19, respectively, 1:10,000) were used. Images were obtained with Odyssey CLx (LI-COR Biosciences).</p></sec><sec id="s4-5"><title>Mass spectrometry</title><sec id="s4-5-1"><title>Multiple reaction monitoring</title><p>Methylhistidine content analysis was performed essentially as previously described (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>). Proteins were precipitated with acetone and hydrolyzed to amino acids with 6 N HCl at 110°C for 24 hr. After dissolving in 25 µl of 5 mM ammonium formate/0.001% formic acid, the amino acids were applied to a LC system (Thermo Fisher Scientific, Vanquish UHPLC). The amino acids loaded on a C18 column (YMC, YMC-Triart C18, 2.0 × 100 mm length, 1.9 µm particle size) were separated at a flow rate of 0.3 ml/min by gradient elution of mobile phase ‘A’ (5 mM ammonium formate with 0.001% formic acid) and mobile phase ‘B’ (acetonitrile) as follows: 0/0 – 1.5/0 – 2/95 – 4/95 – 4.1/0 – 7/0 (min/%B). The effluent was then directed to an electrospray ion source (Thermo Fisher Scientific, HESI-II) connected to a triple quadrupole mass spectrometer (Thermo Fisher Scientific, TSQ Vantage EMR) in positive ion MRM mode. The electrospray was run with the following settings: spray voltage of 3000 V, vaporizer temperature of 450°C, sheath gas pressure of 50 arbitrary units, auxiliary gas pressure of 15 arbitrary units, and collision gas pressure of 1.0 mTorr. The transition of specific MH+→ fragment ions was monitored (His, <italic>m/z</italic> 156.1→83.3, 93.2, and 110.2; π<italic>-N-</italic>MeHis, <italic>m/z</italic> 170.1→95.3, 97.3, and 109.2; τ<italic>-N-</italic>MeHis, <italic>m/z</italic> 170.1→81.3, 83.3, and 124.2). Data were calibrated with 1–250 nM standards (His, π<italic>-N-</italic>MeHis, and τ<italic>-N-</italic>MeHis) at every run. The concentrations of His, π<italic>-N-</italic>MeHis, and τ<italic>-N-</italic>MeHis in the samples were calculated from the calibration curves obtained from the standards.</p></sec></sec><sec id="s4-6"><title>ProSeAM-SILAC-MS</title><p>ProSeAM was synthesized as previously described (<xref ref-type="bibr" rid="bib58">Sohtome et al., 2018</xref>). ProSeAM substrate screening was carried out as reported (<xref ref-type="bibr" rid="bib56">Shimazu et al., 2018</xref>) with some modifications. <italic>METTL18</italic> KO cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing either light Arg/Lys or heavy isotope-labeled Arg (<sup>13</sup>C<sub>6</sub> <sup>15</sup>N<sub>4</sub> <sc>l</sc>-arginine)/Lys (<sup>13</sup>C<sub>6</sub> <sup>15</sup>N<sub>2</sub> <sc>l</sc>-lysine) (Thermo Fisher Scientific, respectively) at least six doubling times. The cells were lysed with 50 mM Tris-HCl pH 8.0, 50 mM KCl, 10% glycerol, and 1% <italic>n</italic>-dodecyl-β-<sc>d</sc>-maltoside. For the cells cultured with the heavy amino acids, the lysate containing 200 μg of proteins was incubated with 150 μM ProSeAM and 10 μg of His-METTL18 in 50 mM Tris-HCl pH 8.0 at 20°C for 2 hr. For the lysate with the light amino acids, His-METTL18 was omitted from the reaction. The reaction was stopped by the addition of four volumes of ice-cold acetone. The proteins were precipitated by centrifugation at 15,000 × <italic>g</italic> for 5 min, washed once with ice-cold acetone, and then dissolved in 58.5 µl of 1× PBS containing 0.2% sodium dodecyl sulfate (SDS). After the addition of 15 µl of 5× click reaction buffer (7.5 mM sodium ascorbate [Nacalai Tesque], 0.5 mM TBTA [AnaSpec], and 5 mM CuSO<sub>4</sub>) and 1.5 µl of 10 mM Azide-PEG4-Biotin (Click Chemistry Tools), the click reaction was conducted for 60 min at room temperature, stopped with four volumes of ice-cold acetone, and precipitated as described above. The protein in the pellet was resuspended in 75 µl of binding buffer (1× PBS, 0.1% Tween-20, 2% SDS, and 20 mM DTT) and sonicated for 10 s. The light and heavy isotope-labeled samples were pooled in 450 µl of IP buffer (Tris-buffered saline [TBS] and 0.1% Tween-20) containing 3 µg of Dynabeads M-280 Streptavidin (Thermo Fisher Scientific) and incubated for 30 min at room temperature (note that the final SDS concentration in the solution was 0.5%). The protein-bound beads were washed three times with bead wash buffer (1× PBS, 0.1% Tween-20, and 0.5% SDS) and twice with 100 mM ammonium bicarbonate (ABC) and then used for Western blotting and MS.</p><p>For MS/MS analysis, the beads were incubated in 20 mM DTT and 100 mM ABC for 30 min at 56°C and then for 30 min at 37°C in the dark with supplementation with 30 mM iodoacetamide. Subsequently, proteins were digested with 1 µg trypsin (Promega) and subjected to LC (Thermo Fisher Scientific, EASY-nLC 1000) coupled to a Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific) with a nanospray ion source in positive mode, as previously reported (<xref ref-type="bibr" rid="bib11">Davydova et al., 2021</xref>). The peptides loaded on a NANO-HPLC C18 capillary column (0.075 mm inner diameter × 150 mm length, 3 µm particle size, Nikkyo Technos) were eluted at a flow rate of 300 nl/min with the two different slopes of mobile phase ‘A’ (water with 0.1% formic acid) and mobile phase ‘B’ (acetonitrile with 0.1% formic acid): 0–30% of phase B in 100 min and 30–65% of phase B in 20 min. Subsequently, the mass spectrometer in the top 10 data-dependent scan mode was run with the following parameters: spray voltage, 2.3 kV; capillary temperature, 275°C; mass-to-charge ratio, 350–1800; normalized collision energy, 28%. The MS and MS/MS data obtained with Xcalibur software (Thermo Fisher Scientific) were surveyed in the Swiss-Prot database with Proteome Discoverer (version 2.3, Thermo Fisher Scientific) and MASCOT search engine software (version 2.7, Matrix Science). Peptides with false discovery rates (FDRs) less than 1% were considered. Proteins with the following criteria were defined as METTL18-dependent labeled proteins: 1.5-fold or more increase in heavy amino acid sample compared to light amino acid sample; one, 10% or more coverage of the protein; and three or more peptides identified.</p></sec><sec id="s4-7"><title>LC-MS/MS for methylated peptide</title><p>The SDS-PAGE-separated and Coomassie staining-visualized proteins were excised and destained. The gel slices were reduced with 50 mM DTT and 4 M guanidine-HCl at 37°C for 2 hr, followed by alkylation with 100 mM acrylamide at 25°C for 30 min. The RPL3 proteins were digested with chymotrypsin. The MS and MS/MS spectra were acquired with a Q Exactive HFX (Thermo Fisher Scientific). The mass spectrometer was operated in positive mode. The MS/MS spectra were obtained using a data-dependent top 10 method. The acquired data were processed using Proteome Discoverer (version 2.3, Thermo Fisher Scientific). The processed data were used to search with MASCOT (version 2.7, Matrix Science) against the in-house database including the amino acid sequences of RPL3 using the following parameters: type of search, MS/MS ion search; enzyme, none; fixed modification, none; variable modifications, Gln-&gt;pyro-Glu (N-term Q), oxidation (M), oropionamide (C), and methyl (H); mass values, monoisotopic; peptide mass tolerance, ±15 ppm; fragment mass tolerance, ±30 mmu; peptide charge, 1+, 2+, and 3+; instrument type, ESI-TRAP.</p></sec><sec id="s4-8"><title>SILAC-MS for <italic>METTL18</italic> KO</title><p>Isotopically heavy amino acids (0.1  mg/ml <sup>13</sup>C<sub>6</sub><sup>15</sup>N<sub>2</sub> <sc>l</sc>-lysine-HCl and 0.1  mg/ml <sup>13</sup>C<sub>6</sub><sup>15</sup>N<sub>4</sub> <sc>l</sc>-arginine-HCl [both FUJIFILM Wako Chemicals]) or regular amino acids (0.1  mg/ml <sc>l</sc>-lysine-HCl and 0.1  mg/ml <sc>l</sc>-arginine-HCl [both FUJIFILM Wako Chemicals]) were added to DMEM deficient in both <sc>l</sc>-lysine and <sc>l</sc>-arginine for SILAC (Thermo Fisher Scientific) supplemented with 10% dialyzed fetal bovine serum (FBS) (Sigma-Aldrich). Naïve HEK293T cells and <italic>METTL18</italic> KO cells were cultured in media with heavy and light isotopes, respectively, for 2 weeks.</p><p>After a brief wash with PBS, cells were lysed with buffer containing 20 mM Tris-Cl pH 7.5, 150 mM KCl, 5 mM MgCl<sub>2</sub>, 1% Triton X-100, and 1 mM DTT. The protein concentration was measured using Qubit 2.0 Fluorometer (Thermo Fisher Scientific). The same amounts of proteins from light and heavy isotope-labeled lysates were mixed and centrifuged at 500 × <italic>g</italic> for 3 min. The supernatant was further centrifuged at 20,000 × <italic>g</italic> and 4°C for 15 min. The precipitate was collected and used for analysis.</p><p>Filter-aided sample preparation (FASP) was used for protein digestion (<xref ref-type="bibr" rid="bib66">Wiśniewski et al., 2009</xref>). The precipitate was dissolved in SDT lysis buffer (4% [w/v] SDS, 0.1 M DTT, and 100 mM Tris-HCl pH 7.6) and incubated at 95°C for 5 min. Denatured samples were diluted 10 times with UA buffer (8 M urea and 100 mM Tris-HCl pH 8.5) and loaded to Vivacon 500, 30000 MWCO Hydrosart (Sartorius) to trap the protein on the filter. The filter unit was washed with the UA buffer. Proteins on the filter unit were alkylated with 100 μl of the IAA solution (0.05 M iodoacetamide in UA). Then, the filter unit was washed with 100 μl of UA buffer three times and 100 μl of 50 mM NH<sub>4</sub>HCO<sub>3</sub> three times. Proteins on the filter unit were digested with 40 μl of trypsin solution (trypsin [V5111, Promega] in 50 mM NH<sub>4</sub>HCO<sub>3</sub>) at 37°C for 18 hr. Then, the peptides were eluted from the filter unit by 40 μl of NH<sub>4</sub>HCO<sub>3</sub> twice and 50 μl of 0.5 M NaCl once and then pooled.</p><p>LC-MS/MS analysis was performed using EASY-nLC 1000 (Thermo Fisher Scientific) and Q Exactive (Thermo Fisher Scientific) equipped with a nanospray ion source. The peptides were separated with a NANO-HPLC capillary column C18 (0.075 × 150 mm, 3 μm, Nikkyo Technos) at 300 nl/min flow rate with strep gradients of solvent A (0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid); 0–30% B for 100 min and then 30–65% B for 20 min. The resulting MS and MS/MS data were searched against the Swiss-Prot database using Proteome Discoverer (version 2.4, Thermo Fisher Scientific) with MASCOT search engine software (version 2.7, Matrix Science). The peptides with FDR values of 0.05 or less were considered for the subsequent analysis. To quantify the difference of peptides labeled with differential isotopes, the built-in SILAC 2-plex quantification method in Proteome Discoverer (version 2.4, Thermo Fisher Scientific) was used. Peptide abundances were normalized by total peptide amount. p-Values were calculated by the background-based <italic>t</italic>-test and then adjusted by the Benjamini–Hochberg method.</p><p>For total proteome analysis, we treated cells with 0.25 μM MG132 (FUJIFILM Wako Chemicals) for 24 hr before cell harvest. Cell lysates were prepared as described above, and the supernatant obtained by centrifugation at 20,000 × <italic>g</italic> and 4°C for 15 min was used for the downstream analysis.</p></sec><sec id="s4-9"><title>Methylation assay</title><p>FLAG-tagged RPL3 was transiently expressed in <italic>METTL18</italic> KO cells and immunopurified with ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich). The purified proteins were incubated in 1× reaction buffer (50 mM Tris-HCl pH 8.5 and 50 mM MgCl<sub>2</sub>) with 1 µg of His-GST-METTL18, 2 µM MTAN, and 0.01 µCi of <sup>14</sup>C-labeled SAM (PerkinElmer) at 30°C for 2 hr. The reaction was stopped by the addition of Laemmli SDS-sample buffer. Proteins were separated on a 10% acrylamide SDS-PAGE gel. The dried gel was exposed to an imaging plate (FUJIFILM) for 48 hr. The autoradiograph was detected with a phosphor imaging scanner (Cytiva, Amersham Typhoon).</p></sec><sec id="s4-10"><title>Cryo-EM</title><p>The crude ribosomal pellet was suspended in buffer A (50 mM Tris-HCl pH 7.5, 150 mM KCl, 4 mM magnesium acetate, 1 mM DTT, 7% [w/v] sucrose, and 1 mM puromycin) by mixing with a magnetic stirrer for 4 hr on ice. After stirring, the suspension was centrifuged at 15,000 × <italic>g</italic> for 10 min at 4°C. The supernatant was loaded onto a HiPrep 16/60 Sephacryl S-500 column (Cytiva) equilibrated with buffer A without puromycin. The fraction was recovered and concentrated using Amicon Ultra (MWCO 50 kDa, Merck Millipore). The concentrated mixture was supplemented with 0.1 mM puromycin, 2 mM magnesium acetate, and 2 mM ATP and incubated for 30 min at 37°C. The reaction was loaded onto a 10–40% (w/v) sucrose gradient with buffer B (50 mM Tris-HCl pH 7.5, 500 mM KCl, 4 mM magnesium acetate, and 2 mM DTT) and centrifuged at 25,000 rpm in an SW28 rotor for 16 hr at 4°C. 2 ml fractions were successively fractionated from the top of the gradient. An aliquot of each fraction was analyzed by SDS-PAGE, and the gels were stained with Coomassie brilliant blue (CBB) to detect the 40S and 60S subunit proteins. The 40S- and 60S-subunit fractions were mixed and concentrated using Amicon Ultra filter units (MWCO 50 kDa, Merck Millipore). The concentrated mixture was loaded onto a 10–50% (w/v) sucrose gradient with buffer C (50 mM Tris-HCl pH 7.5, 150 mM KCl, 10 mM magnesium acetate, and 2 mM DTT) and centrifuged at 28,000 rpm in an SW41Ti rotor for 3 hr at 4°C. Gradient fractionation was carried out using a piston gradient fractionator equipped with a TRIAX flow cell detector (BioComp) by continuous monitoring of absorbance at a wavelength of 280 nm. The fractions containing 80S ribosomes were dialyzed against preparation buffer (10 mM HEPES-KOH pH 7.5, 30 mM potassium acetate, 10 mM magnesium acetate, and 1 mM DTT) and concentrated using Amicon Ultra filter units (MWCO 50 kDa, Merck Millipore). The concentrated sample was quantified by measuring absorbance at a wavelength of 260 nm and flash-cooled with liquid nitrogen.</p><p>For cryo-EM sample preparation, Quantifoil R1.2/1.3 300 mesh copper grids (Quantifoil) were covered with an amorphous carbon layer prepared in-house. The thawed sample was diluted to 70 nM (an absorbance at 260 nm of 3.5) with preparation buffer, and 3 μl of the sample was applied onto grids at 4°C at 100% relative humidity using a Vitrobot Mark IV (FEI). After incubation for 30 s and blotting for 3 s, the grids were plunged into liquid ethane.</p><p>The cryo-EM dataset was collected with a Tecnai Arctica transmission electron microscope (FEI) operated at 200 kV using a K2 summit direct electron detector (Gatan) (0.97 Å/pixel). The 5517 images collected were fractionated to 40 frames, with a total dose of ~50 e<sup>-</sup>/Å<sup>2</sup>.</p><p>Processing of cryo-EM data was performed with RELION-3.1 (<xref ref-type="bibr" rid="bib72">Zivanov et al., 2020</xref>). The movie frames were aligned with MotionCor2 (RELION’s own implementation), and the CTF parameters were estimated with CTFFIND-4.1 (<xref ref-type="bibr" rid="bib53">Rohou and Grigorieff, 2015</xref>). Particles were automatically picked using a template-free Laplacian-of-Gaussian (LoG) filter (250–500 Å), and 381,227 particles were extracted with twofold binning. After 2D classification, 136,688 particles were selected and applied to 3D classification. A low-pass-filtered (40 Å) map of the human 80S ribosome (EMD-9701) (<xref ref-type="bibr" rid="bib70">Yokoyama et al., 2019</xref>) was used as a reference map for 3D classification, and 118,470 particles were selected after this step. These particles were re-extracted without rescaling and used in 3D refinement, Bayesian polishing, CTF refinement, and then 3D refinement again. After these steps, focused refinement with a mask on the 60S subunit and postprocessing resulted in a resolution of 2.72  Å.</p><p>For molecular modeling, the model of the 60S subunit from the human 80S ribosome structure at 2.9 Å resolution (PDB: 6QZP) (<xref ref-type="bibr" rid="bib45">Natchiar et al., 2017</xref>) was used as a starting model and manually fitted into the map using UCSF Chimera (<xref ref-type="bibr" rid="bib51">Pettersen et al., 2004</xref>). Map sharpening and model refinement were performed in PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2010</xref>), and the model was further refined manually with Coot (<xref ref-type="bibr" rid="bib15">Emsley et al., 2010</xref>). The modified nucleotides of ribosomal RNAs were introduced based on quantitative MS data (<xref ref-type="bibr" rid="bib60">Taoka et al., 2018</xref>).</p></sec><sec id="s4-11"><title>Sucrose density gradient</title><p>For <xref ref-type="fig" rid="fig2">Figure 2B</xref>, cells were lysed with whole-cell lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl<sub>2</sub>, 1% NP-40, 1 mM DTT, and 100 µg/ml cycloheximide). The whole-cell lysates were passed through a 21-gauge needle and incubated at 4°C for 15 min. To obtain <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref> and <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2A and B</xref>, cells were lysed with lysis buffer (20 mM Tris-Cl pH 7.5, 150 mM KCl, 5 mM MgCl<sub>2</sub>, 1% Triton X-100, 1 mM DTT, and 100 µg/ml cycloheximide) and cleared by centrifugation at 20,000 × <italic>g</italic> and 4°C for 10 min. Cell lysate containing 40 µg of total RNA was loaded onto a 10–50% sucrose gradient and ultracentrifuged at 35,300 rpm and 4°C for 2.5 hr by a Himac CP80WX ultracentrifuge (Hitachi) with a P40ST rotor (Hitachi).</p><p>To obtain <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C, E, and F</xref>, and <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2C and D</xref>, cells were lysed with EDTA lysis buffer (20 mM Tris-Cl pH 7.5, 150 mM KCl, 5 mM EDTA, 1% Triton X-100, and 1 mM DTT) and centrifuged at 20,000 × <italic>g</italic> and 4°C for 10 min. The supernatant with 40 µg of total RNA was ultracentrifuged at 35,300 rpm and 4°C for 2.5 hr (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>) or at 38,000 rpm and 4°C for 4 hr (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C, E, and F</xref> and <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2C and D</xref>) by a Himac CP80WX ultracentrifuge (Hitachi) with a P40ST rotor (Hitachi).</p><p>To knock down RPL17, HEK293T cells were seeded in complete growth medium in 10 cm<sup>2</sup> dishes 24 hr before siRNA transfection. Then, the cells were transfected with RPL17 siRNA (ON-TARGETplus Human RPL17 siRNA, L-013633-01-0005, Horizon Discovery) or control siRNA (ON-TARGETplus Non-targeting Control Pool, D-001810-10-50, Horizon Discovery) by TransIT-X2 Dynamic Delivery System (Mirus) according to the manufacturer’s instructions. After 72 hr of siRNA transfection, cells were lysed by the procedure described above.</p><p>The gradients were fractionated with continuous measurement of the absorbance at 260 nm by a Triax Flow Cell (BioComp) and Micro collector (ATTO). For ribosomal complex quantification, the straight line connecting the valleys before and after peaks was defined as a background baseline. Then, the area enclosed by the baseline and the peak waveform was calculated. For Western blot (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) or MS analysis (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>), fractions were concentrated using Amicon Ultra filter units (MWCO 10 kDa, Millipore).</p></sec><sec id="s4-12"><title>Newly synthesized protein labeling by OP-puro</title><p>Metabolic labeling of nascent proteins with OP-puro was performed as previously described (<xref ref-type="bibr" rid="bib28">Iwasaki et al., 2019</xref>). Cells were treated with 20 µM OP-puro and incubated at 37°C for 30 min in a CO<sub>2</sub> incubator. After washing with PBS, cells were lysed with buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl<sub>2</sub>, and 1% Triton X-100. Nascent polypeptides were labeled with IRdye800CW Azide (LI-COR Biosciences) with a Click-iT Cell Reaction Buffer Kit (Thermo Fisher Scientific). After free dye was removed by a G-25 column (Cytiva), labeled polypeptides were separated by SDS-PAGE. The gel was imaged by Odyssey CLx (LI-COR Biosciences) for the detection of nascent peptides with infrared at 800 nm. Then, total proteins were stained with CBB (FUJIFILM Wako Chemicals) and imaged with an infrared 700 nm signal. The gel area ranging from 17 kDa to 280 kDa was quantified using Image Studio (version 5.2, LI-COR Biosciences), and the nascent peptide signal was normalized to the total protein signal.</p></sec><sec id="s4-13"><title>Ribosome profiling</title><sec id="s4-13-1"><title>Library preparation</title><p>Ribosome profiling was conducted as previously described (<xref ref-type="bibr" rid="bib40">McGlincy and Ingolia, 2017</xref>; <xref ref-type="bibr" rid="bib42">Mito et al., 2020</xref>). HEK293T cells were cultured in DMEM, high glucose, GlutaMAX Supplement (Thermo Fisher Scientific) supplemented with 10% FBS (Sigma-Aldrich). HAP1 cells were cultured in IMEM (Gibco) supplemented with 10% FBS (Sigma-Aldrich). Both cell lines were maintained at 37°C in a humidified atmosphere containing 5% CO<sub>2</sub>.</p><p>Cell lysates were treated with RNase I, and 17–34-nt protected RNA fragments were gel-excised. After the RNA fragments were ligated with preadenylated linkers, ribosomal RNAs were removed by a Ribo-Zero Gold rRNA Removal Kit (Human/Mouse/Rat) (Illumina, RZG1224). Then, the ligated RNA fragments were reverse-transcribed. The cDNAs were circularized using CircLigaseII (Lucigen) and PCR-amplified. The libraries were sequenced on a HiSeq4000 (Illumina, single reads for 50 nt) for HEK293T cells and a HiSeqX Ten (Illumina, paired ends for 150 nt) for HAP1 cells.</p></sec><sec id="s4-13-2"><title>Data analysis</title><p>After removal of the linker sequences, all reads were aligned to human noncoding RNAs (including rRNA, tRNA, snoRNA, snRNA, and microRNA) using STAR (version 2.7.0a) (<xref ref-type="bibr" rid="bib12">Dobin et al., 2013</xref>). Then, the remaining reads were aligned to the human hg38 reference genome by STAR and assigned to canonical transcripts in the University of California, Santa Cruz (UCSC), known gene reference. For HAP1 cell data, the sequences of reads 1 were corrected by reads 2, before quality filtering and adapter sequence trimming.</p><p>The A-site offsets for each footprint length were empirically estimated: in the dataset with naïve and <italic>METTL18</italic> KO HEK293T cells, 15 for 20–22, 24, and 28–30-nt-long footprints and 16 for 23 and 32–33-nt-long footprints; in the dataset with <italic>METTL18</italic> KO HEK293T cells with METTL18 WT and empty vector expression, 15 for 28–31-nt-long footprints and 16 for 32–33-nt-long footprints; and in the dataset with naïve and <italic>METTL18</italic> KO HAP1 cells, 15 for 28–33-nt-long footprints. The reads of each codon were normalized by the average reads per codon of the transcript. We excluded the first and last 5 codons from the analysis. Transcripts with an average reads per codon of 0.3 or higher were considered. The value of ribosome occupancy was the average of normalized reads at each position.</p><p>To search for motifs associated with Tyr codon around A-site, ribosome occupancies on the seven amino acid motifs were averaged. Motifs with average ribosome occupancy scores greater than 0.3 were used for the downstream analysis. Then, the log<sub>2</sub>-fold changes in <italic>METTL18</italic> KO cells over naïve cells were calculated. Motifs with log<sub>2</sub>-fold changes less than mean –2 SD were subjected to kpLogo (<ext-link ext-link-type="uri" xlink:href="http://kplogo.wi.mit.edu">http://kplogo.wi.mit.edu</ext-link>) (<xref ref-type="bibr" rid="bib67">Wu and Bartel, 2017</xref>).</p></sec></sec><sec id="s4-14"><title>Northern blot</title><p>Total RNA was extracted from cells by TRIzol Reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. Purified RNAs were electrophoresed on Super Sep RNA gels (FUJIFILM Wako Chemicals), transferred onto nylon membranes (Biodyne, Thermo Fisher Scientific), and then UV-crosslinked. The membranes were incubated with UltraHyb-Oligo (Thermo Fisher Scientific) at 37°C for 1 hr. DNA oligonucleotide probes (see below for details) were radiolabeled with [γ−<sup>32</sup>P] ATP (PerkinElmer) by T4 PNK (New England Biolabs) and purified with a G-25 column (Cytiva). After prehybridization, membranes were incubated with a labeled DNA probe overnight at 37°C and washed three times with 2× saline-sodium citrate solution. The signal on the membranes was detected by an Amersham Typhoon (Cytiva) scanner. DNA oligonucleotide sequences used as probes are listed below:</p><p>tRNA<sup>Tyr</sup><sub>GUA</sub>: <named-content content-type="sequence">5′-ACAGTCCTCCGCTCTACCAGCTGA-3′</named-content>, tRNA<sup>Leu</sup><sub>HAG</sub>: <named-content content-type="sequence">5′-CAGCGCCTTAGACCGCTCGGCCA-3′</named-content>, and U6: <named-content content-type="sequence">5′-CACGAATTTGCGTGTCATCCTT-3′</named-content>.</p><list list-type="simple"><list-item><p>The background-subtracted signal was quantified using ImageQuant TL (Cytiva).</p></list-item></list></sec><sec id="s4-15"><title>Hybrid in vitro translation</title><p>The hybrid translation assay was performed as described previously (<xref ref-type="bibr" rid="bib16">Erales et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Panthu et al., 2015</xref>) with optimization for the purpose of this study.</p></sec><sec id="s4-16"><title>mRNA preparation</title><p>For Fluc reporter, a PCR fragment was PCR-amplified from pGL3 basic (Promega) with the primers <named-content content-type="sequence">5′-TGACTAATACGACTCACTATAGG-3′</named-content> and<named-content content-type="sequence"> 5′-TGTATCTTATCATGTCTGCTCGAA-3′</named-content>. For Rluc-Y0×-Fluc and Rluc-Y39×-Fluc reporters, DNA fragments were PCR-amplified by psiCHECK2-Y0× and Y39× with the primers <named-content content-type="sequence">5′-TGACTAATACGACTCACTATAGG-3′ </named-content>and <named-content content-type="sequence">5′-TGTATCTTATCATGTCTGCTCGAA-3′</named-content>.</p><p>The DNA fragments were used for in vitro transcription by T7-Scribe Standard RNA IVT kit (CELLSCRIPT). Then, the RNAs were capped with the ScriptCap m<sup>7</sup>G Capping system (CELLSCRIPT) and polyadenylated with the A-Plus poly(A) polymerase Tailing Kit (CELLSCRIPT).</p></sec><sec id="s4-17"><title>RRL supernatant</title><p>1 ml of RRL (nuclease-treated, Promega) was ultracentrifuged at 240,000 × <italic>g</italic> for 2 hr 15 min at 4°C by an Optima MAX-TL ultracentrifuge (Beckman Coulter) with a TLA110 rotor (Beckman Coulter). Then, 900 μl of supernatant was collected, flash-frozen by liquid nitrogen, and stored at −80°C.</p></sec><sec id="s4-18"><title>Ribosome preparation</title><p>After brief washing with PBS, cells were resuspended with PBS and centrifuged at 500 × <italic>g</italic> for 3 min. The pellet of cells was resuspended in the same volume of buffer R (10 mM HEPES pH 7.5, 10 mM KOAc, 1 mM MgOAc<sub>2</sub>, and 1 mM DTT) and incubated for 15 min on ice. Subsequently, the mixture was vortexed for 30 s and centrifuged at 16,000 × <italic>g</italic> for 10 min at 4°C. Then, 300 μl of the supernatant was ultracentrifuged through a 1 ml sucrose cushion (1 M sucrose in buffer R) at 240,000 × <italic>g</italic> for 2 hr 15 min at 4°C by an Optima MAX-TL ultracentrifuge (Beckman Coulter) with a TLA110 rotor (Beckman Coulter). The pellet was rinsed with buffer R2 (20 mM HEPES pH 7.5, 10 mM NaCl, 25 mM KCl, 1.1 mM MgCl<sub>2</sub>, and 7 mM 2-mercaptoethanol) and then resuspended in 30 μl of buffer R2 by stirring at 4°C for 15 min, flash-frozen by liquid nitrogen, and stored at −80°C. The ribosome concentration was determined by the absorbance at 260 nm using a NanoDrop (Thermo Fisher Scientific).</p></sec><sec id="s4-19"><title>Translation reaction</title><p>In vitro translation was typically performed in a 10 μl reaction mixture containing 5 μl of RRL supernatant, 22.6 nM of purified ribosome, 1.1 nM of reporter mRNA, 75 mM KCl, 0.75 mM MgCl<sub>2</sub>, and 20 µM of amino acid mixture (Promega).</p><p>For the Fluc reporter, the reaction mixture was incubated at room temperature for 90 min and stopped by the addition of 20 μl of 1× Passive Lysis Buffer (Promega). The FLuc luminescence from 30 μl of the mixture was measured with the Dual-Luciferase Reporter Assay System (Promega).</p><p>For Rluc-Y0×-Fluc and Rluc-Y39×-Fluc reporters, the reaction mixture above was scaled up to 120 μl and incubated at room temperature. 10 μl of the reaction mixture was taken as an aliquot every 5 min and mixed with 20 μl of 1× Passive Lysis Buffer (Promega) to stop the reaction. The Rluc and FLuc luminescence from 30 μl of the mixture was measured with the Dual-Luciferase Reporter Assay System (Promega). The luminescences at 20–30 min were used to calculate the slope of Rluc and Fluc synthesis.</p></sec><sec id="s4-20"><title>Proteotoxic-stress reporter assay</title><p>pCI-neo Fluc-EGFP (Addgene plasmid #90170; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:90170; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_90170">:Addgene_90170</ext-link>) or pCI-neo FlucDM-EGFP (Addgene plasmid #90172; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:90172; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_90172">:Addgene_90172</ext-link>) (kind gifts from Franz-Ulrich Hartl) was transfected into naïve cells or <italic>METTL18</italic> KO HEK293T cells by <italic>Trans</italic>IT-293 (Mirus) according to the manufacturer’s instructions. For immunofluorescence staining, cells were cultured on a Nunc Lab-Tek II-CC<sup>2</sup> Chamber Slide system (Thermo Fisher Scientific) and fixed with 4% paraformaldehyde in PBS for 20 min at room temperature. After being washed twice with PBS containing 0.2% Triton X-100, the cells were incubated with Intercept (TBS) Blocking Buffer (LI-COR Biosciences) with 0.2% Triton X-100 for 1 hr at room temperature. After removal of the blocking buffer, the cells were incubated overnight at 4°C with anti-GFP antibody (Abcam, ab1218) diluted 1:1000 with Intercept (TBS) Blocking Buffer with 0.2% Triton X-100. Then, the cells were washed three times with PBS containing 0.2% Triton X-100 and incubated for 1 hr at room temperature with anti-mouse secondary antibody conjugated with Alexa 488 (Thermo Fisher Scientific, R37120) diluted 1:1000 with Intercept (TBS) Blocking Buffer (LI-COR Biosciences) with 0.2% Triton X-100. Then, the cells were washed three times with PBS containing 0.2% Triton X-100. Slide chambers were mounted with VECTASHIELD HardSet Antifade Mounting Medium (Vector Laboratories). Immunofluorescence images were acquired with a FLUOVIEW FV3000 (Olympus).</p><p>To count the aggregation foci, 2 × 10<sup>5</sup> cells were seeded in 35-mm glass-bottom dishes (IWAKI) and cultured for 24 hr. Cells were transfected with 2 µg of pCI-neo Fluc-EGFP or pCI-neo FlucDM-EGFP and 4 µg of PEI (Polysciences) and cultured for an additional 24 hr. GFP fluorescence was observed under an FLUOVIEW FV3000 (Olympus). At least 100 GFP-positive cells were observed to count cells with aggregates (n = 3).</p><p>For MG132 treatment, cells were treated with 0.25 µM MG132 at 24 hr post transfection. After subsequent 24 hr culture, cells were harvested as described in the ‘Ribosome profiling’ section.</p></sec><sec id="s4-21"><title>Assessment of expression levels of ribosomal RNAs</title><p>300 ng of total RNA purified from cell lysates prepared as described in ‘Ribosome profiling’ section was analyzed with a microchip electrophoresis system (MultiNA, Shimadzu).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Funding acquisition, Methodology, Supervision, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-72780-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The ribosome profiling data obtained in this study (GSE179854 and GSE200172) were deposited to the National Center for Biotechnology Information (NCBI). The proteome data for ProSeAM SILAC (ID: PXD026813) were available via ProteomeXchange. The structural coordinates (PDB: 7F5S) and cryo-EM maps (EMDB: EMD-31465) of His245 methylation-deficient ribosomes have been deposited in the Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB), respectively.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Eriko</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>METTL18-mediated histidine methylation on RPL3 modulates translation elongation for proteostasis maintenance</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE179854">GSE179854</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Tadahiro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>ProSeAM SILAC MS screening for METTL18 substrates</data-title><source>jPOST repository</source><pub-id pub-id-type="accession" xlink:href="https://repository.jpostdb.org/preview/27012566060cfe86cb2c91">JPST001223</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Mari</surname><given-names>T</given-names></name><name><surname>Kazuhiro</surname><given-names>K</given-names></name><name><surname>Takuhiro</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>human delta-METTL18 60S ribosome</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7F5S">7F5S</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Eriko</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>METTL18-mediated histidine methylation on RPL3 modulates translation elongation for proteostasis maintenance</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200172">GSE200172</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to all the members of the Iwasaki, Shinkai, Ito, Dohmae, and Sodeoka laboratories for constructive discussion, technical help, and critical reading of the manuscript. This study was supported in mass spectrometry, Sanger sequencing, and confocal microscopy by the Support Unit for Bio-Material Analysis from RIKEN CBS Research Resources Division and in the use of the supercomputer HOKUSAI SailingShip by RIKEN ACCC. This study used the following kindly provided materials: PX330-B/B from Tetsuro Hirose, pL-CRISPR.EFS.tRFP from Benjamin Ebert, pCI-neo Fluc-EGFP and pCI-neo FlucDM-EGFP from Franz-Ulrich Hartl, and a plasmid for <italic>Salmonella</italic> MTAN expression from Vern Schramm. SI was supported by a Grant-in-Aid for Transformative Research Areas (B) 'Parametric Translation' (JP20H05784) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), a Grant-in-Aid for Young Scientists (A) (JP17H04998) and a Challenging Research (Exploratory) (JP19K22406) from the Japan Society for the Promotion of Science (JSPS), AMED-CREST (JP21gm1410001) from the Japan Agency for Medical Research and Development (AMED), and the Pioneering project ('Biology of Intracellular Environments') and Aging Project from RIKEN. Y Shinkai was supported by a Grant-in-Aid for Scientific Research (A) (JP18H03991) and Scientific Research on Innovative Areas 'Chromatin potential for gene regulation' (JP18H05530) from JSPS and the Pioneering project ('Epigenome manipulation') from RIKEN. EMS was supported by a Grant-in-Aid for Scientific Research (C) (JP21K06026) from JPSP and the Collaboration seed fund and Incentive Research Project from RIKEN. TS was supported by a Grant-in-Aid for Scientific Research (C) (JP20K06497) from JSPS. TI was supported by a Grant-in-Aid for Scientific Research (B) (JP19H03172) by JSPS, a Grant-in-Aid for Transformative Research Areas (A) 'Biology of Non-domain Biopolymer' (JP21H05281) by MEXT, the BDR Structural Cell Biology Project, the Pioneering Projects ('Dynamic Structural Biology' and 'Biology of Intracellular Environments'') and Aging Project from RIKEN, and AMED-CREST (JP21gm1410001) from AMED. DNA libraries were sequenced by the Vincent J Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Structural analysis was supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS], JP21am0101082) from AMED.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Bunkóczi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Davis</surname><given-names>IW</given-names></name><name><surname>Echols</surname><given-names>N</given-names></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Oeffner</surname><given-names>R</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Zwart</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmid">20124702</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hadid</surname><given-names>Q</given-names></name><name><surname>Roy</surname><given-names>K</given-names></name><name><surname>Munroe</surname><given-names>W</given-names></name><name><surname>Dzialo</surname><given-names>MC</given-names></name><name><surname>Chanfreau</surname><given-names>GF</given-names></name><name><surname>Clarke</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Histidine methylation of yeast ribosomal protein Rpl3p is required for proper 60S subunit assembly</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>2903</fpage><lpage>2916</lpage><pub-id pub-id-type="doi">10.1128/MCB.01634-13</pub-id><pub-id pub-id-type="pmid">24865971</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hadid</surname><given-names>Q</given-names></name><name><surname>Roy</surname><given-names>K</given-names></name><name><surname>Chanfreau</surname><given-names>G</given-names></name><name><surname>Clarke</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Methylation of yeast ribosomal protein Rpl3 promotes translational elongation fidelity</article-title><source>RNA (New York, N.Y.)</source><volume>22</volume><fpage>489</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1261/rna.054569.115</pub-id><pub-id pub-id-type="pmid">26826131</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname><given-names>JA</given-names></name><name><surname>Cenik</surname><given-names>ES</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Hess</surname><given-names>GT</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Bassik</surname><given-names>MC</given-names></name><name><surname>Fire</surname><given-names>AZ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Translation readthrough mitigation</article-title><source>Nature</source><volume>534</volume><fpage>719</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1038/nature18308</pub-id><pub-id pub-id-type="pmid">27281202</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>PR</given-names></name><name><surname>Scaiola</surname><given-names>A</given-names></name><name><surname>Loughran</surname><given-names>G</given-names></name><name><surname>Leibundgut</surname><given-names>M</given-names></name><name><surname>Kratzel</surname><given-names>A</given-names></name><name><surname>Meurs</surname><given-names>R</given-names></name><name><surname>Dreos</surname><given-names>R</given-names></name><name><surname>O’Connor</surname><given-names>KM</given-names></name><name><surname>McMillan</surname><given-names>A</given-names></name><name><surname>Bode</surname><given-names>JW</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Gatfield</surname><given-names>D</given-names></name><name><surname>Atkins</surname><given-names>JF</given-names></name><name><surname>Ban</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome</article-title><source>Science (New York, N.Y.)</source><volume>372</volume><fpage>1306</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1126/science.abf3546</pub-id><pub-id pub-id-type="pmid">34029205</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biggar</surname><given-names>KK</given-names></name><name><surname>Li</surname><given-names>SS-C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Non-histone protein methylation as a regulator of cellular signalling and function</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>16</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/nrm3915</pub-id><pub-id pub-id-type="pmid">25491103</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassaignau</surname><given-names>AME</given-names></name><name><surname>Cabrita</surname><given-names>LD</given-names></name><name><surname>Christodoulou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>How Does the Ribosome Fold the Proteome?</article-title><source>Annual Review of Biochemistry</source><volume>89</volume><fpage>389</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-062917-012226</pub-id><pub-id pub-id-type="pmid">32569518</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The ribosome: A hot spot for the identification of new types of protein methyltransferases</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>10438</fpage><lpage>10446</lpage><pub-id pub-id-type="doi">10.1074/jbc.AW118.003235</pub-id><pub-id pub-id-type="pmid">29743234</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collart</surname><given-names>MA</given-names></name><name><surname>Weiss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribosome pausing, a dangerous necessity for co-translational events</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>1043</fpage><lpage>1055</lpage></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Horton</surname><given-names>JR</given-names></name><name><surname>Woodcock</surname><given-names>CB</given-names></name><name><surname>Wilkinson</surname><given-names>AW</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gozani</surname><given-names>O</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural basis for the target specificity of actin histidine methyltransferase SETD3</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3541</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11554-6</pub-id><pub-id pub-id-type="pmid">31388018</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davydova</surname><given-names>E</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Schuhmacher</surname><given-names>MK</given-names></name><name><surname>Jakobsson</surname><given-names>ME</given-names></name><name><surname>Willemen</surname><given-names>HLDM</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Moen</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>AYY</given-names></name><name><surname>Małecki</surname><given-names>J</given-names></name><name><surname>Schroer</surname><given-names>L</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Grønsberg</surname><given-names>IA</given-names></name><name><surname>Sohtome</surname><given-names>Y</given-names></name><name><surname>Akakabe</surname><given-names>M</given-names></name><name><surname>Weirich</surname><given-names>S</given-names></name><name><surname>Kikuchi</surname><given-names>M</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><name><surname>Umehara</surname><given-names>T</given-names></name><name><surname>Sodeoka</surname><given-names>M</given-names></name><name><surname>Siino</surname><given-names>V</given-names></name><name><surname>McDonough</surname><given-names>MA</given-names></name><name><surname>Eijkelkamp</surname><given-names>N</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Jeltsch</surname><given-names>A</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name><name><surname>Falnes</surname><given-names>PØ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>891</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20670-7</pub-id><pub-id pub-id-type="pmid">33563959</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics (Oxford, England)</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>JG</given-names></name><name><surname>Foo</surname><given-names>CK</given-names></name><name><surname>Belletier</surname><given-names>NG</given-names></name><name><surname>Gavis</surname><given-names>ER</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ribosome profiling reveals pervasive and regulated stop codon readthrough in <italic>Drosophila melanogaster</italic></article-title><source>eLife</source><volume>2</volume><elocation-id>e01179</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01179</pub-id><pub-id pub-id-type="pmid">24302569</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmott</surname><given-names>E</given-names></name><name><surname>Jovanovic</surname><given-names>M</given-names></name><name><surname>Slavov</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribosome Stoichiometry: From Form to Function</article-title><source>Trends in Biochemical Sciences</source><volume>44</volume><fpage>95</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2018.10.009</pub-id><pub-id pub-id-type="pmid">30473427</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Features and development of Coot</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erales</surname><given-names>J</given-names></name><name><surname>Marchand</surname><given-names>V</given-names></name><name><surname>Panthu</surname><given-names>B</given-names></name><name><surname>Gillot</surname><given-names>S</given-names></name><name><surname>Belin</surname><given-names>S</given-names></name><name><surname>Ghayad</surname><given-names>SE</given-names></name><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Laforêts</surname><given-names>F</given-names></name><name><surname>Marcel</surname><given-names>V</given-names></name><name><surname>Baudin-Baillieu</surname><given-names>A</given-names></name><name><surname>Bertin</surname><given-names>P</given-names></name><name><surname>Couté</surname><given-names>Y</given-names></name><name><surname>Adrait</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Therizols</surname><given-names>G</given-names></name><name><surname>Yusupov</surname><given-names>M</given-names></name><name><surname>Namy</surname><given-names>O</given-names></name><name><surname>Ohlmann</surname><given-names>T</given-names></name><name><surname>Motorin</surname><given-names>Y</given-names></name><name><surname>Catez</surname><given-names>F</given-names></name><name><surname>Diaz</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evidence for rRNA 2’-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes</article-title><source>PNAS</source><volume>114</volume><fpage>12934</fpage><lpage>12939</lpage><pub-id pub-id-type="doi">10.1073/pnas.1707674114</pub-id><pub-id pub-id-type="pmid">29158377</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Escamilla</surname><given-names>AM</given-names></name><name><surname>Rousseau</surname><given-names>F</given-names></name><name><surname>Schymkowitz</surname><given-names>J</given-names></name><name><surname>Serrano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins</article-title><source>Nature Biotechnology</source><volume>22</volume><fpage>1302</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1038/nbt1012</pub-id><pub-id pub-id-type="pmid">15361882</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulay</surname><given-names>SP</given-names></name><name><surname>Bista</surname><given-names>S</given-names></name><name><surname>Varshney</surname><given-names>A</given-names></name><name><surname>Kirmizialtin</surname><given-names>S</given-names></name><name><surname>Sanbonmatsu</surname><given-names>KY</given-names></name><name><surname>Dinman</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tracking fluctuation hotspots on the yeast ribosome through the elongation cycle</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>4958</fpage><lpage>4971</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx112</pub-id><pub-id pub-id-type="pmid">28334755</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Liao</surname><given-names>S</given-names></name><name><surname>Kwiatkowski</surname><given-names>S</given-names></name><name><surname>Tomaka</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name><name><surname>Min</surname><given-names>J</given-names></name><name><surname>Drozak</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural insights into SETD3-mediated histidine methylation on β-actin</article-title><source>eLife</source><volume>8</volume><elocation-id>e43676</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43676</pub-id><pub-id pub-id-type="pmid">30785395</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Kasturi</surname><given-names>P</given-names></name><name><surname>Bracher</surname><given-names>A</given-names></name><name><surname>Loew</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Villella</surname><given-names>A</given-names></name><name><surname>Garza</surname><given-names>D</given-names></name><name><surname>Hartl</surname><given-names>FU</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Firefly luciferase mutants as sensors of proteome stress</article-title><source>Nature Methods</source><volume>8</volume><fpage>879</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1697</pub-id><pub-id pub-id-type="pmid">21892152</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Shichino</surname><given-names>Y</given-names></name><name><surname>Schneider-Poetsch</surname><given-names>T</given-names></name><name><surname>Mito</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>S</given-names></name><name><surname>Udagawa</surname><given-names>T</given-names></name><name><surname>Kohno</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Mishima</surname><given-names>Y</given-names></name><name><surname>Inada</surname><given-names>T</given-names></name><name><surname>Iwasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genome-wide Survey of Ribosome Collision</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107610</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107610</pub-id><pub-id pub-id-type="pmid">32375038</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckl</surname><given-names>D</given-names></name><name><surname>Kowalczyk</surname><given-names>MS</given-names></name><name><surname>Yudovich</surname><given-names>D</given-names></name><name><surname>Belizaire</surname><given-names>R</given-names></name><name><surname>Puram</surname><given-names>RV</given-names></name><name><surname>McConkey</surname><given-names>ME</given-names></name><name><surname>Thielke</surname><given-names>A</given-names></name><name><surname>Aster</surname><given-names>JC</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>941</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1038/nbt.2951</pub-id><pub-id pub-id-type="pmid">24952903</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>R</given-names></name><name><surname>Gendron</surname><given-names>JM</given-names></name><name><surname>Rising</surname><given-names>L</given-names></name><name><surname>Mak</surname><given-names>R</given-names></name><name><surname>Webb</surname><given-names>K</given-names></name><name><surname>Kaiser</surname><given-names>SE</given-names></name><name><surname>Zuzow</surname><given-names>N</given-names></name><name><surname>Riviere</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Fenech</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Lindsay</surname><given-names>SA</given-names></name><name><surname>Christianson</surname><given-names>JC</given-names></name><name><surname>Hampton</surname><given-names>RY</given-names></name><name><surname>Wasserman</surname><given-names>SA</given-names></name><name><surname>Bennett</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Unfolded Protein Response Triggers Site-Specific Regulatory Ubiquitylation of 40S Ribosomal Proteins</article-title><source>Molecular Cell</source><volume>59</volume><fpage>35</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.04.026</pub-id><pub-id pub-id-type="pmid">26051182</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Patchett</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Sawyer</surname><given-names>S</given-names></name><name><surname>Press</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Understanding Biases in Ribosome Profiling Experiments Reveals Signatures of Translation Dynamics in Yeast</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005732</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005732</pub-id><pub-id pub-id-type="pmid">26656907</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imami</surname><given-names>K</given-names></name><name><surname>Milek</surname><given-names>M</given-names></name><name><surname>Bogdanow</surname><given-names>B</given-names></name><name><surname>Yasuda</surname><given-names>T</given-names></name><name><surname>Kastelic</surname><given-names>N</given-names></name><name><surname>Zauber</surname><given-names>H</given-names></name><name><surname>Ishihama</surname><given-names>Y</given-names></name><name><surname>Landthaler</surname><given-names>M</given-names></name><name><surname>Selbach</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phosphorylation of the Ribosomal Protein RPL12/uL11 Affects Translation during Mitosis</article-title><source>Molecular Cell</source><volume>72</volume><fpage>84</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.08.019</pub-id><pub-id pub-id-type="pmid">30220558</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Ghaemmaghami</surname><given-names>S</given-names></name><name><surname>Newman</surname><given-names>JRS</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title><source>Science (New York, N.Y.)</source><volume>324</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1126/science.1168978</pub-id><pub-id pub-id-type="pmid">19213877</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>S</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Growing Toolbox for Protein Synthesis Studies</article-title><source>Trends in Biochemical Sciences</source><volume>42</volume><fpage>612</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2017.05.004</pub-id><pub-id pub-id-type="pmid">28566214</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>S</given-names></name><name><surname>Iwasaki</surname><given-names>W</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>C</given-names></name><name><surname>Shichino</surname><given-names>Y</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Mito</surname><given-names>M</given-names></name><name><surname>Dodo</surname><given-names>K</given-names></name><name><surname>Sodeoka</surname><given-names>M</given-names></name><name><surname>Imataka</surname><given-names>H</given-names></name><name><surname>Honma</surname><given-names>T</given-names></name><name><surname>Fukuzawa</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA</article-title><source>Molecular Cell</source><volume>73</volume><fpage>738</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.11.026</pub-id><pub-id pub-id-type="pmid">30595437</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname><given-names>K</given-names></name><name><surname>Mankin</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action</article-title><source>Annals of the New York Academy of Sciences</source><volume>1241</volume><fpage>33</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2011.06315.x</pub-id><pub-id pub-id-type="pmid">22191525</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapasi</surname><given-names>P</given-names></name><name><surname>Chaudhuri</surname><given-names>S</given-names></name><name><surname>Vyas</surname><given-names>K</given-names></name><name><surname>Baus</surname><given-names>D</given-names></name><name><surname>Komar</surname><given-names>AA</given-names></name><name><surname>Fox</surname><given-names>PL</given-names></name><name><surname>Merrick</surname><given-names>WC</given-names></name><name><surname>Mazumder</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>L13a blocks 48S assembly: role of a general initiation factor in mRNA-specific translational control</article-title><source>Molecular Cell</source><volume>25</volume><fpage>113</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.11.028</pub-id><pub-id pub-id-type="pmid">17218275</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kater</surname><given-names>L</given-names></name><name><surname>Thoms</surname><given-names>M</given-names></name><name><surname>Barrio-Garcia</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Ismail</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>YL</given-names></name><name><surname>Bange</surname><given-names>G</given-names></name><name><surname>Kressler</surname><given-names>D</given-names></name><name><surname>Berninghausen</surname><given-names>O</given-names></name><name><surname>Sinning</surname><given-names>I</given-names></name><name><surname>Hurt</surname><given-names>E</given-names></name><name><surname>Beckmann</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Visualizing the Assembly Pathway of Nucleolar Pre-60S Ribosomes</article-title><source>Cell</source><volume>171</volume><fpage>1599</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.039</pub-id><pub-id pub-id-type="pmid">29245012</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisly</surname><given-names>I</given-names></name><name><surname>Kattel</surname><given-names>C</given-names></name><name><surname>Remme</surname><given-names>J</given-names></name><name><surname>Tamm</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Luciferase-based reporter system for in vitro evaluation of elongation rate and processivity of ribosomes</article-title><source>Nucleic Acids Research</source><volume>49</volume><elocation-id>e59</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkab121</pub-id><pub-id pub-id-type="pmid">33684199</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>S</given-names></name><name><surname>Seliga</surname><given-names>AK</given-names></name><name><surname>Vertommen</surname><given-names>D</given-names></name><name><surname>Terreri</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Grabowska</surname><given-names>I</given-names></name><name><surname>Tiebe</surname><given-names>M</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name><name><surname>Jagielski</surname><given-names>AK</given-names></name><name><surname>Veiga-da-Cunha</surname><given-names>M</given-names></name><name><surname>Drozak</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SETD3 protein is the actin-specific histidine <italic>N</italic>-methyltransferase</article-title><source>eLife</source><volume>7</volume><elocation-id>e37921</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.37921</pub-id><pub-id pub-id-type="pmid">30526847</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lareau</surname><given-names>LF</given-names></name><name><surname>Hite</surname><given-names>DH</given-names></name><name><surname>Hogan</surname><given-names>GJ</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Distinct stages of the translation elongation cycle revealed by sequencing ribosome-protected mRNA fragments</article-title><source>eLife</source><volume>3</volume><elocation-id>e01257</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01257</pub-id><pub-id pub-id-type="pmid">24842990</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Woolford</surname><given-names>JL</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural snapshot of cytoplasmic pre-60S ribosomal particles bound by Nmd3, Lsg1, Tif6 and Reh1</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>24</volume><fpage>214</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3364</pub-id><pub-id pub-id-type="pmid">28112732</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Małecki</surname><given-names>JM</given-names></name><name><surname>Odonohue</surname><given-names>MF</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Jakobsson</surname><given-names>ME</given-names></name><name><surname>Gessa</surname><given-names>L</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Davydova</surname><given-names>E</given-names></name><name><surname>Moen</surname><given-names>A</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Thiede</surname><given-names>B</given-names></name><name><surname>Gleizes</surname><given-names>PE</given-names></name><name><surname>Leidel</surname><given-names>SA</given-names></name><name><surname>Falnes</surname><given-names>PØ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>3185</fpage><lpage>3203</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab088</pub-id><pub-id pub-id-type="pmid">33693809</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malyutin</surname><given-names>AG</given-names></name><name><surname>Musalgaonkar</surname><given-names>S</given-names></name><name><surname>Patchett</surname><given-names>S</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nmd3 is a structural mimic of eIF5A, and activates the cpGTPase Lsg1 during 60S ribosome biogenesis</article-title><source>The EMBO Journal</source><volume>36</volume><fpage>854</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.15252/embj.201696012</pub-id><pub-id pub-id-type="pmid">28179369</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuki</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>Y</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>S</given-names></name><name><surname>Yoko</surname><given-names>H</given-names></name><name><surname>Udagawa</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>Y</given-names></name><name><surname>Yoshihisa</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Inada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ribosomal protein S7 ubiquitination during ER stress in yeast is associated with selective mRNA translation and stress outcome</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>19669</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-76239-3</pub-id><pub-id pub-id-type="pmid">33184379</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazumder</surname><given-names>B</given-names></name><name><surname>Sampath</surname><given-names>P</given-names></name><name><surname>Seshadri</surname><given-names>V</given-names></name><name><surname>Maitra</surname><given-names>RK</given-names></name><name><surname>DiCorleto</surname><given-names>PE</given-names></name><name><surname>Fox</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control</article-title><source>Cell</source><volume>115</volume><fpage>187</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00773-6</pub-id><pub-id pub-id-type="pmid">14567916</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlincy</surname><given-names>NJ</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptome-wide measurement of translation by ribosome profiling</article-title><source>Methods (San Diego, Calif.)</source><volume>126</volume><fpage>112</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2017.05.028</pub-id><pub-id pub-id-type="pmid">28579404</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meskauskas</surname><given-names>A</given-names></name><name><surname>Dinman</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A molecular clamp ensures allosteric coordination of peptidyltransfer and ligand binding to the ribosomal A-site</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>7800</fpage><lpage>7813</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq641</pub-id><pub-id pub-id-type="pmid">20660012</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mito</surname><given-names>M</given-names></name><name><surname>Mishima</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protocol for Disome Profiling to Survey Ribosome Collision in Humans and Zebrafish</article-title><source>STAR Protocols</source><volume>1</volume><elocation-id>100168</elocation-id><pub-id pub-id-type="doi">10.1016/j.xpro.2020.100168</pub-id><pub-id pub-id-type="pmid">33377062</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>F</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Buskirk</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A systematically-revised ribosome profiling method for bacteria reveals pauses at single-codon resolution</article-title><source>eLife</source><volume>8</volume><elocation-id>e42591</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42591</pub-id><pub-id pub-id-type="pmid">30724162</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murn</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The winding path of protein methylation research: milestones and new frontiers</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>18</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.35</pub-id><pub-id pub-id-type="pmid">28512349</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natchiar</surname><given-names>SK</given-names></name><name><surname>Myasnikov</surname><given-names>AG</given-names></name><name><surname>Kratzat</surname><given-names>H</given-names></name><name><surname>Hazemann</surname><given-names>I</given-names></name><name><surname>Klaholz</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Visualization of chemical modifications in the human 80S ribosome structure</article-title><source>Nature</source><volume>551</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1038/nature24482</pub-id><pub-id pub-id-type="pmid">29143818</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedialkova</surname><given-names>DD</given-names></name><name><surname>Leidel</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity</article-title><source>Cell</source><volume>161</volume><fpage>1606</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.022</pub-id><pub-id pub-id-type="pmid">26052047</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>1518</fpage><lpage>1527</lpage><pub-id pub-id-type="doi">10.1101/gad.1001502</pub-id><pub-id pub-id-type="pmid">12080090</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>Z</given-names></name><name><surname>Star</surname><given-names>AT</given-names></name><name><surname>Mierzwa</surname><given-names>A</given-names></name><name><surname>Lanouette</surname><given-names>S</given-names></name><name><surname>Mayne</surname><given-names>J</given-names></name><name><surname>Couture</surname><given-names>JF</given-names></name><name><surname>Figeys</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A charge-suppressing strategy for probing protein methylation</article-title><source>Chemical Communications (Cambridge, England)</source><volume>52</volume><fpage>5474</fpage><lpage>5477</lpage><pub-id pub-id-type="doi">10.1039/c6cc00814c</pub-id><pub-id pub-id-type="pmid">27021271</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterman</surname><given-names>IA</given-names></name><name><surname>Wieland</surname><given-names>M</given-names></name><name><surname>Maviza</surname><given-names>TP</given-names></name><name><surname>Lashkevich</surname><given-names>KA</given-names></name><name><surname>Lukianov</surname><given-names>DA</given-names></name><name><surname>Komarova</surname><given-names>ES</given-names></name><name><surname>Zakalyukina</surname><given-names>YV</given-names></name><name><surname>Buschauer</surname><given-names>R</given-names></name><name><surname>Shiriaev</surname><given-names>DI</given-names></name><name><surname>Leyn</surname><given-names>SA</given-names></name><name><surname>Zlamal</surname><given-names>JE</given-names></name><name><surname>Biryukov</surname><given-names>MV</given-names></name><name><surname>Skvortsov</surname><given-names>DA</given-names></name><name><surname>Tashlitsky</surname><given-names>VN</given-names></name><name><surname>Polshakov</surname><given-names>VI</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Polikanov</surname><given-names>YS</given-names></name><name><surname>Bogdanov</surname><given-names>AA</given-names></name><name><surname>Osterman</surname><given-names>AL</given-names></name><name><surname>Dmitriev</surname><given-names>SE</given-names></name><name><surname>Beckmann</surname><given-names>R</given-names></name><name><surname>Dontsova</surname><given-names>OA</given-names></name><name><surname>Wilson</surname><given-names>DN</given-names></name><name><surname>Sergiev</surname><given-names>PV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel</article-title><source>Nature Chemical Biology</source><volume>16</volume><fpage>1071</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0578-x</pub-id><pub-id pub-id-type="pmid">32601485</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panthu</surname><given-names>B</given-names></name><name><surname>Décimo</surname><given-names>D</given-names></name><name><surname>Balvay</surname><given-names>L</given-names></name><name><surname>Ohlmann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vitro translation in a hybrid cell free lysate with exogenous cellular ribosomes</article-title><source>The Biochemical Journal</source><volume>467</volume><fpage>387</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1042/BJ20141498</pub-id><pub-id pub-id-type="pmid">25628018</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Greenblatt</surname><given-names>DM</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Paredes</surname><given-names>M</given-names></name><name><surname>Lyko</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The importance of non-histone protein methylation in cancer therapy</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>20</volume><fpage>569</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0147-x</pub-id><pub-id pub-id-type="pmid">31270441</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohou</surname><given-names>A</given-names></name><name><surname>Grigorieff</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CTFFIND4: Fast and accurate defocus estimation from electron micrographs</article-title><source>Journal of Structural Biology</source><volume>192</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.08.008</pub-id><pub-id pub-id-type="pmid">26278980</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanghai</surname><given-names>ZA</given-names></name><name><surname>Miller</surname><given-names>L</given-names></name><name><surname>Molloy</surname><given-names>KR</given-names></name><name><surname>Barandun</surname><given-names>J</given-names></name><name><surname>Hunziker</surname><given-names>M</given-names></name><name><surname>Chaker-Margot</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chait</surname><given-names>BT</given-names></name><name><surname>Klinge</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modular assembly of the nucleolar pre-60S ribosomal subunit</article-title><source>Nature</source><volume>556</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1038/nature26156</pub-id><pub-id pub-id-type="pmid">29512650</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Barjau</surname><given-names>J</given-names></name><name><surname>Sohtome</surname><given-names>Y</given-names></name><name><surname>Sodeoka</surname><given-names>M</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Selenium-based S-adenosylmethionine analog reveals the mammalian seven-beta-strand methyltransferase METTL10 to be an EF1A1 lysine methyltransferase</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e105394</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0105394</pub-id><pub-id pub-id-type="pmid">25144183</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Furuse</surname><given-names>T</given-names></name><name><surname>Balan</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>I</given-names></name><name><surname>Okuno</surname><given-names>S</given-names></name><name><surname>Iwanari</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Hamakubo</surname><given-names>T</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Wakana</surname><given-names>S</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of METTL20 in regulating β-oxidation and heat production in mice under fasting or ketogenic conditions</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>1179</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-19615-4</pub-id><pub-id pub-id-type="pmid">29352221</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simsek</surname><given-names>D</given-names></name><name><surname>Barna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An emerging role for the ribosome as a nexus for post-translational modifications</article-title><source>Current Opinion in Cell Biology</source><volume>45</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.02.010</pub-id><pub-id pub-id-type="pmid">28445788</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohtome</surname><given-names>Y</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name><name><surname>Barjau</surname><given-names>J</given-names></name><name><surname>Fujishiro</surname><given-names>S</given-names></name><name><surname>Akakabe</surname><given-names>M</given-names></name><name><surname>Terayama</surname><given-names>N</given-names></name><name><surname>Dodo</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name><name><surname>Sodeoka</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Unveiling epidithiodiketopiperazine as a non-histone arginine methyltransferase inhibitor by chemical protein methylome analyses</article-title><source>Chemical Communications (Cambridge, England)</source><volume>54</volume><fpage>9202</fpage><lpage>9205</lpage><pub-id pub-id-type="doi">10.1039/c8cc03907k</pub-id><pub-id pub-id-type="pmid">30063235</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>KC</given-names></name><name><surname>Frydman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The stop-and-go traffic regulating protein biogenesis: How translation kinetics controls proteostasis</article-title><source>The Journal of Biological Chemistry</source><volume>294</volume><fpage>2076</fpage><lpage>2084</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV118.002814</pub-id><pub-id pub-id-type="pmid">30504455</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taoka</surname><given-names>M</given-names></name><name><surname>Nobe</surname><given-names>Y</given-names></name><name><surname>Yamaki</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Izumikawa</surname><given-names>K</given-names></name><name><surname>Yamauchi</surname><given-names>Y</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Isobe</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Landscape of the complete RNA chemical modifications in the human 80S ribosome</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>9289</fpage><lpage>9298</lpage><pub-id pub-id-type="doi">10.1093/nar/gky811</pub-id><pub-id pub-id-type="pmid">30202881</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuorto</surname><given-names>F</given-names></name><name><surname>Legrand</surname><given-names>C</given-names></name><name><surname>Cirzi</surname><given-names>C</given-names></name><name><surname>Federico</surname><given-names>G</given-names></name><name><surname>Liebers</surname><given-names>R</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Ehrenhofer-Murray</surname><given-names>AE</given-names></name><name><surname>Dittmar</surname><given-names>G</given-names></name><name><surname>Gröne</surname><given-names>HJ</given-names></name><name><surname>Lyko</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Queuosine-modified tRNAs confer nutritional control of protein translation</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>e99777</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201899777</pub-id><pub-id pub-id-type="pmid">30093495</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Parshin</surname><given-names>AV</given-names></name><name><surname>Shcherbik</surname><given-names>N</given-names></name><name><surname>Pestov</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Reduced expression of the mouse ribosomal protein Rpl17 alters the diversity of mature ribosomes by enhancing production of shortened 5.8S rRNA</article-title><source>RNA (New York, N.Y.)</source><volume>21</volume><fpage>1240</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1261/rna.051169.115</pub-id><pub-id pub-id-type="pmid">25995445</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>KJ</given-names></name><name><surname>Zurita-Lopez</surname><given-names>CI</given-names></name><name><surname>Al-Hadid</surname><given-names>Q</given-names></name><name><surname>Laganowsky</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>BD</given-names></name><name><surname>Lipson</surname><given-names>RS</given-names></name><name><surname>Souda</surname><given-names>P</given-names></name><name><surname>Faull</surname><given-names>KF</given-names></name><name><surname>Whitelegge</surname><given-names>JP</given-names></name><name><surname>Clarke</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A novel 3-methylhistidine modification of yeast ribosomal protein Rpl3 is dependent upon the YIL110W methyltransferase</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>37598</fpage><lpage>37606</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.170787</pub-id><pub-id pub-id-type="pmid">20864530</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>A</given-names></name><name><surname>Iwasaki</surname><given-names>S</given-names></name><name><surname>McGourty</surname><given-names>CA</given-names></name><name><surname>Medina-Ruiz</surname><given-names>S</given-names></name><name><surname>Teerikorpi</surname><given-names>N</given-names></name><name><surname>Fedrigo</surname><given-names>I</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Rape</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cell-fate determination by ubiquitin-dependent regulation of translation</article-title><source>Nature</source><volume>525</volume><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nature14978</pub-id><pub-id pub-id-type="pmid">26399832</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>AW</given-names></name><name><surname>Diep</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Ooi</surname><given-names>YS</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>T-M</given-names></name><name><surname>Horton</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Trivedi</surname><given-names>DV</given-names></name><name><surname>Ruppel</surname><given-names>KM</given-names></name><name><surname>Vilches-Moure</surname><given-names>JG</given-names></name><name><surname>Casey</surname><given-names>KM</given-names></name><name><surname>Mak</surname><given-names>J</given-names></name><name><surname>Cowan</surname><given-names>T</given-names></name><name><surname>Elias</surname><given-names>JE</given-names></name><name><surname>Nagamine</surname><given-names>CM</given-names></name><name><surname>Spudich</surname><given-names>JA</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Carette</surname><given-names>JE</given-names></name><name><surname>Gozani</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>SETD3 is an actin histidine methyltransferase that prevents primary dystocia</article-title><source>Nature</source><volume>565</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0821-8</pub-id><pub-id pub-id-type="pmid">30626964</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiśniewski</surname><given-names>JR</given-names></name><name><surname>Zougman</surname><given-names>A</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Universal sample preparation method for proteome analysis</article-title><source>Nature Methods</source><volume>6</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1322</pub-id><pub-id pub-id-type="pmid">19377485</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>kpLogo: positional k-mer analysis reveals hidden specificity in biological sequences</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>W534</fpage><lpage>W538</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx323</pub-id><pub-id pub-id-type="pmid">28460012</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CC-C</given-names></name><name><surname>Zinshteyn</surname><given-names>B</given-names></name><name><surname>Wehner</surname><given-names>KA</given-names></name><name><surname>Green</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-Resolution Ribosome Profiling Defines Discrete Ribosome Elongation States and Translational Regulation during Cellular Stress</article-title><source>Molecular Cell</source><volume>73</volume><fpage>959</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.12.009</pub-id><pub-id pub-id-type="pmid">30686592</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Souquere</surname><given-names>S</given-names></name><name><surname>Chujo</surname><given-names>T</given-names></name><name><surname>Kobelke</surname><given-names>S</given-names></name><name><surname>Chong</surname><given-names>YS</given-names></name><name><surname>Fox</surname><given-names>AH</given-names></name><name><surname>Bond</surname><given-names>CS</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Pierron</surname><given-names>G</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional Domains of NEAT1 Architectural lncRNA Induce Paraspeckle Assembly through Phase Separation</article-title><source>Molecular Cell</source><volume>70</volume><fpage>1038</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.019</pub-id><pub-id pub-id-type="pmid">29932899</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Machida</surname><given-names>K</given-names></name><name><surname>Iwasaki</surname><given-names>W</given-names></name><name><surname>Shigeta</surname><given-names>T</given-names></name><name><surname>Nishimoto</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Yonemochi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>Y</given-names></name><name><surname>Shigematsu</surname><given-names>H</given-names></name><name><surname>Shirouzu</surname><given-names>M</given-names></name><name><surname>Tadakuma</surname><given-names>H</given-names></name><name><surname>Imataka</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HCV IRES Captures an Actively Translating 80S Ribosome</article-title><source>Molecular Cell</source><volume>74</volume><fpage>1205</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.04.022</pub-id><pub-id pub-id-type="pmid">31080011</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular basis for histidine N3-specific methylation of actin H73 by SETD3</article-title><source>Cell Discovery</source><volume>6</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-019-0135-5</pub-id><pub-id pub-id-type="pmid">31993215</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname><given-names>J</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in <italic>RELION</italic>-3.1</article-title><source>IUCrJ</source><volume>7</volume><fpage>253</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1107/S2052252520000081</pub-id><pub-id pub-id-type="pmid">32148853</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>METTL18</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NM_033418</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>RPL3</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NM_000967</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>METTL18</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NM_027279</td><td align="left" valign="bottom">cDNA clone AK139786 (FANTOM) was used</td></tr><tr><td align="left" valign="bottom">Gene (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>RPL3</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NM_013762</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">Naïve HEK293T</td><td align="left" valign="bottom">RIKEN BRC</td><td align="left" valign="bottom">RCB2202</td><td align="left" valign="bottom">Female</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>METTL18</italic> KO HEK293T</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Female; CRISPR/Cas9-edited cell line, knocking out <italic>METTL18</italic></td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>METTL18</italic> KO HEK293T with stable METTL18 expression</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Female; exogenous METTL18 expression was induced in <italic>METTL18</italic> KO HEK293T</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>SETD3</italic> KO HEK293T</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Female; CRISPR/Cas9-edited cell line, knocking out <italic>SETD3</italic></td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom"><italic>SETD3</italic>-METTL18 DKO HEK293T</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Female; CRISPR/Cas9-edited cell line, knocking out <italic>SETD3 and METTL18</italic> simultaneously</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">Naïve HAP1</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">Cat# C631</td><td align="left" valign="bottom">Male</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HAP1<break/>1-nt deletion</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">Cat# HZGHC000541c009</td><td align="left" valign="bottom">Male; CRISPR/Cas9-edited cell line containing a 1-nt deletion in a coding exon of METTL18</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HAP1<break/>2-nt deletion</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">Cat#<break/>HZGHC000541c012</td><td align="left" valign="bottom">Male; CRISPR/Cas9-edited cell line containing a 2-nt deletion in a coding exon of METTL18</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HAP1<break/>4-nt deletion</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">Cat#<break/>HZGHC000541c002</td><td align="left" valign="bottom">Male; CRISPR/Cas9-edited cell line containing a 4-nt deletion in a coding exon of METTL18</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">PX330-B/B-gMETTL18</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Guide RNA expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pL-CRISPR.EFS.tRFP-gSETD3</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Guide RNA expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pcDNA3-hRPL3-FLAG (WT and His245Ala)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pcDNA3-mRPL3-FLAG (WT and His245Ala)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pQCXIP-hMETTL18-HA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">hMETTL18-Asp193Lys-Gly195Arg-Gly197Arg-HA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">siRNA to RPL17</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">L-013633-<break/>01-0005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">Control siRNA</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">D-001810-<break/>10-50</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct<break/>(<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pCI-neo Fluc-EGFP</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_90170">:Addgene_90170</ext-link></td><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Transfected construct<break/>(<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">pCI-neo FlucDM-EGFP</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_90172">:Addgene_90172</ext-link></td><td align="left" valign="bottom">Protein expression</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-α-tubulin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# T5168; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477579">:AB_477579</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-METTL18 (rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech Group</td><td align="left" valign="bottom">Cat# 25553-1-AP; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2503968">:AB_2503968</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SETD3 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab174662; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2750852">:AB_2750852</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RPL3 (mouse monoclonal)</td><td align="left" valign="bottom">Proteintech Group</td><td align="left" valign="bottom">Cat# 66130-1-lg; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2881529">:AB_2881529</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RPL3 (rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech Group</td><td align="left" valign="bottom">Cat# 11005-1-AP; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2181760">:AB_2181760</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PES1 (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab252849; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2915993">:AB_2915993</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NMD3 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab170898; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2915994">:AB_2915994</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HA (mouse monoclonal)</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">Cat# M180-3; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10951811">:AB_10951811</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab6556; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_305564">:AB_305564</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-actin (mouse monoclonal)</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">Cat# M177-3; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10697039">:AB_10697039</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, conjugate with HRP (sheep polyclonal)</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">Cat# NA931V; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_772210">:AB_772210</ext-link></td><td align="left" valign="bottom">WB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG, conjugated with HRP (donkey polyclonal)</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">Cat# NA934V; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_772206">:AB_772206</ext-link></td><td align="left" valign="bottom">WB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, conjugated with IRDye 680RD (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 925-68070; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2651128">:AB_2651128</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG, conjugated with IRDye 680RD (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 925-68071; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2721181">:AB_2721181</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, conjugated with IRDye 800CW (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926-32210; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_621842">:AB_621842</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG, conjugated with IRDye 800CW (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926-32211; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_621843">:AB_621843</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rat IgG, conjugated with IRDye 800CW (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926-32219; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1850025">:AB_1850025</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab1218; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_298911">:AB_298911</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, conjugated with Alexa Fluor 488 (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# R37120; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556548">:AB_2556548</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET19b-mMETTL18</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression of N-terminally His-tagged mouse METTL18 in <italic>Escherichia coli</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCold-GST-mMETTL18</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression of N-terminally His- and GST-tagged mouse METTL18 in <italic>E. coli</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom"><italic>Salmonella</italic> MTAN</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_64041">:Addgene_64041</ext-link></td><td align="left" valign="bottom">Expression of <italic>Salmonella</italic> MTAN in <italic>E. coli</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL3 basic</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat#<break/>E1751</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">psiCHECK2</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat#<break/>C8021</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">psiCHECK2-Y0×</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Encoding Rluc-Fluc fusion</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">psiCHECK2-Y39×</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Encoding Rluc-Fluc fusion with Tyr repeat insertion</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Probe for tRNA<sup>Tyr</sup><sub>GUA</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5′-ACAGTCCTCCGCTCTACCAGCTGA-3′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Probe for tRNA<sup>Leu</sup><sub>HAG</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5′-CAGCGCCTTAGACCGCTCGGCCA-3′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Probe for U6</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5′-CACGAATTTGCGTGTCATCCTT-3′</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QuikChange Site-Directed Mutagenesis Kit</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">Cat# 200518</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PEI transfection reagent</td><td align="left" valign="bottom">Polysciences</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TransIT-293</td><td align="left" valign="bottom">Mirus</td><td align="left" valign="bottom">Cat# MIR2700</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TransIT-X2 Dynamic Delivery System</td><td align="left" valign="bottom">Mirus</td><td align="left" valign="bottom">Cat# MIR6000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Dual-Luciferase Reporter Assay System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# E1910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Rabbit Reticulocyte Lysate, Nuclease-Treated</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# L4960</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-iT Cell Reaction Buffer Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# C10269</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">T7-Scribe Standard RNA IVT kit</td><td align="left" valign="bottom">CELLSCRIPT</td><td align="left" valign="bottom">Cat# C-MSC11610</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ScriptCap m<sup>7</sup>G Capping system</td><td align="left" valign="bottom">CELLSCRIPT</td><td align="left" valign="bottom">Cat# C-SCCE0625</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">A-Plus poly(A) polymerase Tailing kit</td><td align="left" valign="bottom">CELLSCRIPT</td><td align="left" valign="bottom">Cat# C-PAP5104H</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">IRdye800CW azide</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 929-65000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MG132</td><td align="left" valign="bottom">FUJIFILM Wako Chemicals</td><td align="left" valign="bottom">Cat# 139-18451</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Proteome Discoverer</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Version 2.3</td><td align="left" valign="bottom">LC-MS/MS for methylated peptide</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Proteome Discoverer</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Version 2.4</td><td align="left" valign="bottom">SILAC-MS</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MASCOT</td><td align="left" valign="bottom">Matrix Science</td><td align="left" valign="bottom">Version 2.7</td><td align="left" valign="bottom">LC-MS/MS for methylated peptide and SILAC-MS</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RELION-3.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1107/S2052252520000081">https://doi.org/10.1107/S2052252520000081</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CTFFIND-4.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsb.2015.08.008">https://doi.org/10.1016/j.jsb.2015.08.008</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">PHENIX</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1107/S0907444909052925">https://doi.org/10.1107/S0907444909052925</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Coot</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1107/S0907444910007493">https://doi.org/10.1107/S0907444910007493</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Image Studio</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Version 5.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/bts635">https://doi.org/10.1093/bioinformatics/bts635</ext-link></td><td align="left" valign="bottom">Version 2.7.0a</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">kpLog</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkx323">https://doi.org/10.1093/nar/gkx323</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://kplogo.wi.mit.edu">http://kplogo.wi.mit.edu</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72780.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qing</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.07.29.454307" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.07.29.454307"/></front-stub><body><p>This study investigates METTLL18-mediated RPL3 histidine methylation on 245 position and how it regulates translation elongation and protects cells from cellular aggregation of Tyr-rich proteins. The study potentially provides some new example of ‘ribosome code’ and how ribosome PTM could affect protein translation.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72780.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Qing</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zhang</surname><given-names>Qing</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Walker</surname><given-names>Sarah E</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y64my43</institution-id><institution>The State University of New York at Buffalo</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.07.29.454307">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.07.29.454307v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;METTL18-mediated histidine methylation on RPL3 modulates translation elongation for proteostasis maintenance&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Qing Zhang as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Volker Dötsch as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Sarah E Walker (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Experimentally address the discrepancy between the current study and recently published study.</p><p>2) In addition, authors need to examine whether the phenotype of METTL18KO is mediated through change with RPL3 methylation as well as Tyr codons/faster peptidyl transfer.</p><p>3) More evidence is needed for claiming strongly that methylation slows translocation specifically. If not, the statement may need to tune down. Also, the claims with regarding to ribosome code or translation tuning need to tune down.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>It is my opinion that authors experiments and data on Tyrosine specific effects and proteostatsis maintenance are not fully supported by the current experimental data. These would be the major novelty in the manuscript in the comparison to the previously published work by Malecki et al., 2021. There are several reasons for my concerns:</p><p>1. The effects on Tyr codons are seen in HEK293 cells but not in HAP1 cells (used in work by Malecki et al., 2021) even though the experimental approach (ribosome profiling) and genetic manipulation (CRISPR/Cas9 KO of METTL18) is done in the same/similar way. Assuming that authors analyzed data from the previously published study (Malecki et al., 2021) and did not find effects on Tyr codons would authors argue for the cell specific effects of RPL3 His245 methylation?</p><p>2. Current explanation of the aggregation data is purely speculative. Protein folding is a complex process and proteins with less tyrosine residues would be affected by this mechanism based on the position of tyrosine residues in the folding core of the particular protein. If the authors argument is that translation rate impacts overall protein folding due to the number of Tyr residues in protein. One would expect to see drastic change in translation rate and abundance of certain proteins. Is this indeed the case?</p><p>3. In respect to the point mentioned in 2. MACROH2A1is a protein with 8 Tyr codons and 2 depicted in the figure 5H are found in the C-termini of the protein not influencing either histone or macro domain folding or structure. Are other Tyr codons in this protein impacted by METTL18 KO?</p><p>4. If the effect of protein aggregation in METTL18 KO is dependent solely on Tyr codons and the faster peptidyl transfer (not decoding) would depleting pull of charged Tyr tRNAs and not tRNA abundance (as authors tested) be a good control. One could target tyrosyl-tRNA synthetase by siRNA or shRNA and reduce protein aggregation in METTL18 KO?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Please add number of replicates for experiments to the methods and/or figure legends.</p><p>Please add antibody dilutions used to the methods section.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72780.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Experimentally address the discrepancy between the current study and recently published study.</p></disp-quote><p>As recommended, we conducted ribosome profiling of the HAP1 cells with <italic>METTL18</italic> KO. For this assay, we employed 3 cell lines, including the same cell line used in an earlier report (Małecki <italic>et al. NAR</italic> 2021). Indeed, we observed similarly enhanced elongation on Tyr codons (<italic>i.e.</italic>, reduction of footprints on the codons) in the <italic>METTL18</italic> KO HAP1 cell lines as in the <italic>METTL18</italic> KO HEK293T cells that we originally used. Although we still do not have any explanation for the difference between our data and the published ribosome profiling data, the new data supported our conclusion that RPL3 methylation exerts amino acid-specific effects on elongation.</p><disp-quote content-type="editor-comment"><p>2) In addition, authors need to examine whether the phenotype of METTL18KO is mediated through change with RPL3 methylation as well as Tyr codons/faster peptidyl transfer.</p></disp-quote><p>To directly address the effect of RPL3 methylation on Tyr codon elongation, we harnessed the <italic>Renilla</italic>–firefly luciferase fusion reporter system (Kisly <italic>et al. NAR</italic> 2021) and hybrid in vitro translation (Panthu <italic>et al. Biochem J</italic> 2015 and Erales <italic>et al. PNAS</italic> 2017). Using this setup, we observed that ribosomes isolated from <italic>METTL18</italic> KO cells perform faster elongation of Tyr codons. Given the direct comparison of ribosomes with and without RPL3 methylation, these data provide solid evidence of a relationship between RPL3 methylation and translation elongation at Tyr codons.</p><disp-quote content-type="editor-comment"><p>3) More evidence is needed for claiming strongly that methylation slows translocation specifically. If not, the statement may need to tune down. Also, the claims with regarding to ribosome code or translation tuning need to tune down.</p></disp-quote><p>Although the in vitro translation mentioned above showed direct evidence that Tyr codon elongation is retarded by methylated RPL3, understanding, the specificity in more detail would require further experiments. Thus, we modified our description of the data to avoid claims of pinpointing the affected step in elongation processes (such as peptidyl transfer or translocation) throughout the manuscript. Additionally, we avoided using “ribosome code” and “translation tuning” in the manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>It is my opinion that authors experiments and data on Tyrosine specific effects and proteostatsis maintenance are not fully supported by the current experimental data. These would be the major novelty in the manuscript in the comparison to the previously published work by Malecki et al., 2021. There are several reasons for my concerns:</p><p>1. The effects on Tyr codons are seen in HEK293 cells but not in HAP1 cells (used in work by Malecki et al., 2021) even though the experimental approach (ribosome profiling) and genetic manipulation (CRISPR/Cas9 KO of METTL18) is done in the same/similar way. Assuming that authors analyzed data from the previously published study (Malecki et al., 2021) and did not find effects on Tyr codons would authors argue for the cell specific effects of RPL3 His245 methylation?</p></disp-quote><p>As suggested, we performed ribosome profiling on 3 independent KO lines in HAP1 cells, including the one used in the NAR paper (<italic>METTL18</italic> KO, 2-nt del.). Indeed, all <italic>METTL18</italic> KO HAP1 cells showed a reduction in footprints at Tyr codons, as observed in HEK293 cells (see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> and Figure 4H), and thus, there was a consistent effect of RPL3 methylation on elongation irrespective of the cell type. On the other hand, we could not find such a trend (see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) by reanalysis of the published data (Małecki <italic>et al. NAR</italic> 2021).</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-sa2-fig1-v1.tif"/></fig><p>Thus far, we could not find the origin of the difference in ribosome profiling compared to the earlier paper. Culturing conditions or others may affect the data. Given that, we amended the discussion to cover the potential of context/situation-dependent effects of RPL3 methylation.</p><disp-quote content-type="editor-comment"><p>2. Current explanation of the aggregation data is purely speculative. Protein folding is a complex process and proteins with less tyrosine residues would be affected by this mechanism based on the position of tyrosine residues in the folding core of the particular protein. If the authors argument is that translation rate impacts overall protein folding due to the number of Tyr residues in protein. One would expect to see drastic change in translation rate and abundance of certain proteins. Is this indeed the case?</p></disp-quote><p>We thank the reviewer for the constructive suggestion. Here, we performed additional SILAC experiments to assess the total proteome alterations (see Figure 8). To evaluate the fraction of proteins degraded, we combined this approach with treatment with MG132, a proteasome inhibitor (Figure 8A). This approach indeed revealed a subset of proteins that were actively broken down in <italic>METTL18</italic> KO cells (Figure 8B); the amount of these proteins was reduced in <italic>METTL18</italic> KO cells and was recovered by MG132 treatment. This group of proteins included those enriched with Tyr residues (Figure 8C). Thus, enhanced elongation of Tyr residues leads to proteins being susceptible to proteasomal degradation. In other words, RPL3 methylation by METTL18 maintains the proteome integrity from such an imbalance between the synthesis and degradation of proteins.</p><disp-quote content-type="editor-comment"><p>3. In respect to the point mentioned in 2. MACROH2A1is a protein with 8 Tyr codons and 2 depicted in the figure 5H are found in the C-termini of the protein not influencing either histone or macro domain folding or structure. Are other Tyr codons in this protein impacted by METTL18 KO?</p></disp-quote><p>Accordingly, we depicted the whole CDS of MACROH2A1 (Figure 7 — figure supplement 1C) for footprint read accumulation and aggregation percentage provided by TANGO. MACROH2A1 has 7 Tyr codons, and 3 of them overlap with aggregation-prone regions (amino acid positions at 47, 336, and 349). In addition to 336 and 349 highlighted in Figure 7E, we prepared an additional zoomed-up panel for position 47 in Figure 7 — figure supplement 1D. All 3 positions were accompanied by reduced footprints with METTL18 depletion.</p><disp-quote content-type="editor-comment"><p>4. If the effect of protein aggregation in METTL18 KO is dependent solely on Tyr codons and the faster peptidyl transfer (not decoding) would depleting pull of charged Tyr tRNAs and not tRNA abundance (as authors tested) be a good control. One could target tyrosyl-tRNA synthetase by siRNA or shRNA and reduce protein aggregation in METTL18 KO?</p></disp-quote><p>We truly appreciate this constructive suggestion. We did indeed try knockdown of tyrosyl-tRNA synthetase by siRNA in HEK293T cells with FlucDM aggregation reporter expression. However, we noted that siRNA transfection <italic>per se</italic> was quite stressful to cells so that FlucDM was highly aggregated even in the naïve HEK293T cells (see <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>), comparable to untransfected <italic>METTL18</italic> KO cells (see Figure 6B). Therefore, the suggested experiments were unfortunately challenging. Instead, we modified the statement in the manuscript and avoided claiming to have pinpointed the step (<italic>i.e.</italic>, peptidyl transfer or translocation) that RPL3 methylation affects.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-72780-sa2-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Please add number of replicates for experiments to the methods and/or figure legends.</p></disp-quote><p>According to the reviewer's suggestion, we amended the figure legends to clearly describe the replicate numbers.</p><disp-quote content-type="editor-comment"><p>Please add antibody dilutions used to the methods section.</p></disp-quote><p>According to the reviewer's suggestion, we added the corresponding information to the methods section and key resource table.</p></body></sub-article></article>